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Abstract 
The input of emerging pollutants into the natural environment is of considerable concern 
due to their potential implications for the health and development of humans and wildlife. 
Knowledge of the occurrence and removal (by sewage treatment) of these chemicals is 
limited and there is a need for these to be investigated if the transport and fate of these 
chemicals is to be better understood. To develop our understanding, reliable, accurate and 
precise measurements of these compounds at the very low (often sub-nanogram) 
concentrations at which they may be found, and may still be toxic, is crucial. However, as a 
result of the increasing international concern, increasing research attention has led to a large 
number of analytical techniques described as being suitable for the analysis of these 
compounds; this fragmentation and lack of collaborative focus is likely to have resulted in a 
lack of refinement of the techniques employed. In this research, a number of these proposed 
analytical and sample pre-treatment techniques have been assessed, both by internal 
experimentation and through inter-calibration with collaborating laboratories, to identify 
which techniques are best suited to further development for research in this area, and have 
subsequently been optimised, to examine the removal efficacy of traditional and novel 
sewage treatment techniques, and to monitor EDC and Pharmaceutical concentrations in 
several UK rivers.   
Monitoring of the river Ray, Swindon, UK over a period of three years, using spot-
sampling and 24-hour and 7-day integrated sampling, combined with solid-phase extraction 
(SPE) followed mass spectrometric analyses, showed stable EDC and pharmaceutical 
levels, typical of comparable rivers throughout the EU, but with a significant reduction in 
concentrations after the installation of a granular activated charcoal plant at the Rodbourne 
Sewage Treatment Works (STW) of which the river Ray is a conduit. These results were in 
agreement with results from analyses biological assays, such as yeast estrogen screening 
performed independently by another laboratory.  
 
7 
 
List of abbreviations 
CEFAS 
CEH 
CFUF 
CI 
CRM 
Defra 
Centre for ecology, fisheries and aquaculture science 
Centre for ecology and hydrology 
Cross-flow ultrafiltration 
Chemical Ionisation 
Certified Reference Material 
Department for the environment, food and rural affairs (UK)  
EEQ Estrogenecity (in Estradiol Equivalents) 
EI 
EPI 
Electron Impact 
Estimation Programs Interface 
eV Electron Volts 
GAC Granular Activated Carbon 
GC Gas Chromatography 
GC-MS Gas Chromatography with mass spectrometry 
GC-MS/MS Gas Chromatography with tandem mass spectrometry 
GPC Gel Permeation Chromatography 
HPLC High Performance Liquid Chromatography 
8 
 
IS Internal Standard 
Kcoc  
Koc 
Kow 
Kp 
Colloidal organic carbon normalized partition coefficient 
Organic carbon normalized partition coefficient 
Octanol/water partition coefficient 
Sediment/Water partition coefficient 
 
LC Liquid Chromatography 
LC-MS/MS Liquid Chromatography with tandem mass spectrometry 
LOD Limit of Detection 
LOQ 
MAE 
Limit of Quantification 
Microwave assisted extraction 
m/z Mass-to-charge ratio 
MRM Multiple Reaction Monitoring  
NP 
POCIS 
PML 
RF 
Normal Phase 
Polar organic chemical integrative sampler 
Plymouth Marine Laboratory 
Response Factor 
9 
 
RRF Relative Response Factor 
RP 
RSD 
RT 
SD 
Reverse Phase 
Relative standard deviation 
Retention time 
Standard deviation 
SIM 
SPE 
US EPA 
Selected Ion Monitoring 
Solid phase extraction 
United States (of America) Environmental Protection Agency 
 
Chemical abbreviations 
ACN 
DCM 
Acetonitrile 
Dichloromethane 
EDC Endocrine Disrupting Chemical 
E1 Estrone 
E2 Estradiol 
EE2 
IPA 
Ethinylestradiol 
Isopropyl alcohol 
10 
 
OP 
NP 
MeOH 
Octylphenol 
Nonylphenol 
Methanol 
PAH 
PPCP 
Polycyclic Aromatic Hydrocarbon 
Pharmaceuticals and Personal Care Product 
POP Persistent Organic Pollutant 
Pro Propanolol 
Sul Sulfamethaoxazole 
Meb Mebeverine 
Thio Thioridazine 
Carb Carbamazepine 
Tamo Tamoxifen 
Meco Mecoprop 
Indo Indomethacine 
Diclo Diclofenac 
 
 
11 
 
Chapter 1. Introduction  
In recent years, with advances in analytical techniques, emerging pollutants have 
received considerable attention from the scientific and political community [1][2][3][4]. Of 
these, endocrine disrupting chemicals (EDCs) and residues of pharmaceutical and personal 
care products (PPCPs) have been shown to have deleterious effects for wildlife and humans 
and have subsequently been at the forefront of scientific and legislative concern.  
Exposure to EDCs can have an effect on organisms, as well as potential 
implications for progeny. In wildlife, feminisation of fish and other aquatic organisms after 
exposure to EDCs has been well-documented, with the potential to reduce fertility and 
impact upon fish populations [5][6]. Additionally, there is an increasing body of evidence 
to suggest implications for humans, including lower sperm counts, undescended testicles, 
early puberty, thyroid dysfunction and cancers [7][8]. As well as physiological 
implications, there is growing concern of the behavioural effects of EDCs and has been 
linked to neurodevelopment disorders including attention-deficit hyperactivity disorder 
(ADHD), autism and intellectual impairment [7]. In wildlife, alterations such as in sexual 
behaviour and aggression have been observed [9]. 
  There are over three-thousand pharmaceutically active compounds in use, 
not including personal care products (e.g. ingredients used in cosmetics) or illicit drugs 
[10]. The number of compounds suspected of exhibiting endocrine-disrupting effects is 
more difficult to quantify, because EDCs transcend typical chemical classes and there is no 
formal classification or registration system. However, 127 pesticides have been identified 
as exhibiting such effects [11], on top of some 60 compounds which have similarly been 
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identified in other chemical classes [12], the EU recently recognised over 546 „suspected‟ 
EDCs in a list which notably omits the steroidal estrogens, perhaps due to a lack of 
understanding of their environmental persistence and the focus of the report on industrial 
chemicals [13]. Whilst some EDCs and PPCPs degrade rapidly in the environment, where 
they are continuously emitted, even rapidly degrading substances can exhibit pseudo-
persistent behaviour; others may persist in the environment due to their chemical properties 
and may be classed as persistent organic pollutants (POPs). Among EDCs, estrone (E1), 
17β-estradiol (E2) and 17α-ethinylestradiol (EE2) exhibit the most potent estrogenic 
activity and are of greatest concern [14]. 
 Although some EDCs may be naturally occurring, the majority are anthropogenic in 
origin and the occurrence of these and pharmaceutical residues in the environment, in 
particular aquatic environs has increased proportionally to the growth in their use. Potential 
inputs of EDCs and PPCPs to the environment are numerous, including agricultural run-off 
[15], hospital and pharmaceutical waste [16], industrial waste and spillage incidents [17]. 
However, sewage effluent is widely accepted to be the primary source of the majority of 
EDCs and PPCPs [18].  
 Due to the potential risk to the health of both humans and wildlife, there is 
widespread acknowledgement of the need to better understand the occurrence of emerging 
pollutants, to ascertain whether they are present at levels which are sufficient to incite 
deleterious effects, and subsequently if the risk they pose is of concern. Risk assessment of 
this kind requires the ability to robustly monitor these compounds, which to date has 
proved a major scientific challenge, particularly where these compounds are present in the 
environment at very low, yet still potentially toxic, concentrations.  
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In light of the potential risk, however, national and international authorities are keen to 
prevent the release of EDCs as well as other emerging pollutants into the environment as a 
precaution. As such,  granular activated carbon (GAC) has been shown, through 
laboratory-based experimentation [19][20], to be suitable for the removal of a range of 
synthetic organic chemicals and dissolved naturally-occurring chemicals from wastewater, 
including several EDCs and PPCPs, and was commissioned at a UK sewage treatment 
works (STP) approximately midway through the experimentation stage of this work to 
enhance the removal of organic pollutants. 
 
1.1 Aims and objectives 
1.1.1 Research Aims 
The broad aim of this thesis is to determine the occurrence of selected EDCs and 
pharmaceuticals in water and wastewater and to understand their removal in wastewater by 
novel post-tertiary techniques. 
1.1.2 Objectives 
I. To develop robust and optimised analytical methods for the selected 
compounds  
II. To assess the spatial and temporal variability of the selected compounds in 
wastewater and river water 
III. To assess the efficiency of granular activated carbon (GAC) in the removal 
of the selected compounds in wastewater 
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1.1.3 Thesis layout 
This thesis is comprised of 8 chapters, 4 of which are experimental. Chapter 1 
provides a broad introduction to the subject and briefly describes the background to 
the study. It additionally includes the aims and objectives underpinning the research 
which this thesis covers. Chapter 2 includes a comprehensive summary of the state 
of scientific knowledge on the subject of EDCs and pharmaceuticals as 
environmental pollutants and a review of the literature relevant to this research. In 
chapter 3, the materials and methods used throughout the experimental work are 
described and discussed. In chapter 4, three popular techniques for the analysis of 
the most potent EDCs - the estrogenic steroids E1, E2 and EE2 in environmental 
water are examined to determine which is most suitable. Chapter 5 discusses a 
number of techniques to improve the analysis of environmental estrogenic steroids 
in environmental matrices, including the experimental comparison of numerous 
popular stabilisation techniques and the use of gel permeation chromatography 
(GPC) to enhance spectrometric analyses. Chapters 6 and 7 discuss the occurrence 
of EDCs and pharmaceuticals respectively in environmental matrices, and their 
removal by sewage treatment processes. Chapter 8 provides a summary of the data 
presented throughout this thesis and reiterates the conclusions drawn. It additionally 
contains suggestions for further work, the need for which have become apparent 
from the data presented in this thesis.  
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Chapter 2. Review of the relevant literature 
2.1. Introduction 
    Water pollution from emerging pollutants, which are those chemicals that have 
recently been shown to occur in water resources and are identified as being a potential 
environmental or health risk, and yet adequate data do not exist to determine their risk.  
Although many of these pollutants have half-lives (t½) significantly lower than more 
conventional pollutants such as polycyclic aromatic hydrocarbons (PAHs)[1], their 
continual release into the environment results in their „psuedo-persistance‟. Their research 
has become an important aspect of current environmental research due to the largely 
unknown risk posed by their potential toxic effects on wildlife and humans [2-4] and the 
increasing importance of freshwater resources as a result of an increasing human population 
and the effects of climate change. As can be seen in table 2.1 there are a wide-range of 
chemicals which are currently described as „emerging pollutants‟, indeed, it has been 
estimated that some 55,000 commercial chemicals have the potential to enter the 
environment [5],  the majority of which, until 2007 were poorly regulated, due to a lack of 
comprehensive legislation which required testing only of „new‟ chemical substances. In 
2007, the European Registration, Evaluation, Authorisation and Restriction of Chemicals 
(REACH) directive was introduced. This directive places greater emphasis on the 
manufacturers, traders and users of all chemical substances which are produced or imported 
above 1 tonne/year to discern the properties of chemical substances and subsequently 
register this information on a Europe-wide central database, with exemptions for substances 
that are already adequately regulated by other legislation, such as medicines, water, oxygen, 
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some noble gases, most polymers (although monomers may need to be registered) and 
natural substances which have not been chemically altered, such as cement and ore.  
Due to the increasing importance of freshwater resources, as a result of increasing 
populations and climate change, it becomes critical that we understand the input, transport 
and fate of micropollutant chemicals, which, together with toxicological information, afford 
the assessment of risk that they pose to human and wildlife health. Such substances include 
endocrine disrupting chemicals (EDCs), pharmaceuticals and personal care products 
(PPCPs), the focus of this work, which are acknowledged to be continuously introduced to 
the environment, primarily as a result of their incomplete removal in sewage treatment 
works (STWs). Consequently, implications for wildlife have been observed – EDCs in the 
environment have been linked to the feminisation of fish; commonly evidenced by the 
presence of the egg-yolk protein, vitellogenin (Vg) in male fish, and diclofenac, a 
commonly-used pharmaceutical has been shown to accumulate, with a concentration factor 
of up to 2732, in the liver of rainbow trout and causes histopathological alterations in both 
the kidneys and gills [6] In vulture populations this drug has been shown to cause renal 
failure and has resulted in a significant population decline in Pakistan [7].  
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Table 2.1 Examples of emerging pollutants  
Class Sub-class Example compounds 
Algal toxins Cyanotoxics Microcystin-LR 
Antifoaming agents   Surfinol-104 
Antioxidants   2,6-Di-tert-butylphenol  
4-tert-Butylphenol  
Antifouling compounds Antifouling compounds Irgarol 
 Organotin compounds Dibutyl Tin ion 
Triphenyltin ion 
Biocides   Triclosan 
Methyltriclosan 
Chlorophene 
Bio-terrorism agents   Chloropicrin 
Detergents Ethoxylates/carboxylates of 
octyl/nonyl phenols 
Octylphenols 
Nonylphenols  
Disinfection by-products   Cyanoformaldehyde,  
Decabromodiphenyl ethane 
N-Nitrosodimethylamine 
Flame retardants Polybrominated 
diphenylethers 
Heptabromodiphenyl ethers 
Pentabromodiphenyl ethers 
  Brominated flame retardants Bisphenol A  
Decabromodiphenyl ethane 
Fragrances Fragrances Camphor 
d-limonene 
 Terpineol 
  Polycyclic musks Galaxolide 
Drugs of abuse Illicit and illegal drugs Cocaine 
Heroin 
Morphine 
Codeine 
Nanoparticles Silicon-based Silicon Carbide 
 Fullerenes Carbon-60 (Buckyballs) 
 Metal-based Titanium Dioxide 
Personal care products Sun-screen agents Benzophenone,  
  Insect repellants N,N-diethyl-m-toluamide  
 Parabens Methyl-paraben 
Pharmaceuticals   Carbamazepine 
Diclofenac 
Caffeine 
Ethinylestradiol 
Plasticizers Phthalates Benzylbutylphthalate  
Diethylphthalate  
  Other Bisphenol A 
Triphenyl phosphate  
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2.2 Routes of entry of emerging pollutants into the aquatic environment 
Human activity is the majority source of the emerging pollutants that enter the 
environment. The wastewaters from our homes and places of work contain not only a 
multitude of excreted chemicals of both natural and synthetic origin, but also the chemicals 
we use for our personal care, cosmetic and cleaning purposes. Most STWs are not designed 
for the removal of these chemicals, and as a result, many pass through the sedimentation 
and biological processes that these plants employ, into waterways via effluent. Thus, the 
primary route of entry to the aquatic environment is from household and industrial waste 
waters via the outfall from STWs. There are, however, other routes of entry, such as: run-
off from pavements, roads and agricultural land; atmospheric deposition, bathing, residues 
from hospitals and pharmaceutical manufacturing, illicit drug manufacturing, fish farming, 
leaking landfills and the deliberate disposal of unwanted medications into waste waters or 
directly into waterways.  
Livestock excreta run-off, directly from fields into the river systems, is another viable route 
of entry for steroidal hormones and veterinary drugs. However, animal waste is not 
processed at STWs and the final effluent pumped out into rivers.  Instead, it is directly or 
indirectly excreted straight onto the soil. In the UK, where large numbers of farm animals, 
such as cows and sheep, vastly outnumber the human population, and so represent a major 
possible source of emerging pollutants. However, the half-lives (t1/2) of estrone (E1) and 
17β-estradiol (E2) have been shown to be significantly reduced in soil, under certain 
environmental and climatic conditions [8]. It has been shown however that dairy farm 
effluents have the potential to deliver high levels of E1 to water systems [9] due to the 
population density of cows and the amount of steroid estrogens that a cow excretes – 2 
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orders of magnitude higher than a human [10]. The degradation of two growth-promoting 
steroids in cattle have been previously studied [11] by implanting trenbolone acetate, an 
androgen, into the ears of male and female cattle and feeding them with feed laced with 
melengestrol acetate, a progestin. It was found that 10 % of both steroids were excreted, 
and, when the manure was stored, the t1/2 was 260 d. When the liquefied manure was spread 
onto fields the t1/2 decreased to 7 d for trenbolone acetate and 2 months for melengestrol 
acetate. However, the authors were unable to determine what share of the chemicals‟ 
disappearances could be explained by microbial degradation or by run-off. The t1/2 of E1 
and E2 have also been examined [12] and it has been shown that in unamended soils the t1/2 
of E1 and E2 was 5 – 25 d, depending on soil type. In soils amended with animal manure 
the rate of degradation of these two chemicals was more rapid (1 – 9 d). They concluded 
that “the risk of freshwater contamination by estrogens due to normal landspreading rates 
and methods was low”. Studies into the run-off of nine PPCPs (Atenolol, Carbamazepine, 
Cotinine, Gemfibrozil, Naproxen, Ibuprofen, Acetaminophen, Sulfamethoxazole and 
Triclosan) applied to field plots via biosolid slurry, using both subsurface injection and 
broadcast application, with simulated precipitation [13]. PPCPs in run-off from the injected 
plots were found at levels < LOD, whereas 7 of the compounds were detected in levels 
ranging from 70 -1477 ηg/L in run-off from the broadcast application. This suggests that 
subsurface injection or ploughing of fields directly after slurry treatment could eliminate 
surface run-off of PPCPs.  
The transport and fate of organic compounds in the aquatic environment are determined by 
chemical, physical, and biological processes. These processes include: volatilization, 
absorption, wet and dry deposition, microbial degradation, sorption, hydrolysis, aquatic 
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photolysis, oxidation, chemical reaction, bio-concentration, advection, and dispersion. The 
relative importance of each of these processes depends on the characteristics of the organic 
compound and also of the aquatic system itself. 
 
 
 
 
 
 
 
 
 
 
 
Compound Name 
and molecular formula 
Structure 
 
Molecular 
Mass 
Log Kow 
Kcoc 
(L/kg) 
LogBCF 
Aqueous 
solubility 
(mg/L) 
Estrone 
C18H22O2 
 
270 3.43 
2.97x10
3
-
2.22x10
5
 
1.77-
4.15 
13-146.8 
Estradiol 
C18H24O2 
 
272 
3.94 
 
6.40x10
2
-
1.91x10
4
 
2.23-
3.97 
3.9-81.9 
Ethinylestradiol 
C20H24O2 
 
296 
3.67-
4.15 
0.72x10
3
-
5.6x10
4
 
1.15-
3.92 
4.8-
116.4 
Propranolol 
C16H21NO2 
 
259 3.48 2.82-9.01x10
2
 1.71 61-228 
Sulfamethoxazole 
 
253 0.89 2.58x10
2
 
0.168-
0.5 
610-
3942 
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C10H11N3O3S 
Mebeverine 
C25H35NO5 
 
466 5.12 5.4x10
3
-1.3x10
5
 
1.81-
3.04 
0.05-
0.80 
Thioridazine 
C21H26N2S2 
 
370 
5.90-
6.45 
1.14x10
4
-
1.24x10
5
 
1.97-
3.56 
0.03-
0.14 
Carbamazepine 
C15H12N2O  
236 
2.25-
2.45 
1.68x10
2
-
1.33x10
3
 
1.28 
17.66-
12.0 
Tamoxifen 
C26H29NO 
 
371 6.30 
2.51x10
4
-
2.61x10
6
 
3.09-
3.83 
0.02-
0.10 
Mecoprop 
C10H11ClO3  
214 
2.94-
3.13 
4.85x10-
9.58x10 
0.50-
2.11 
168-860 
24 
 
Indomethacine 
C19H16ClNO4 
 
357 
4.23-
4.27 
2.20 x10
2
-
8.01x10
2
 
0.50-
2.93 
0.81-
3.11 
Diclofenac 
C14H11Cl2NO2 
 
296 
4.02-
4.15 
4.04 x10
2
-
4.57x10
2
 
0.50-
3.15 
2.37-
10.89 
meclofenamic acid 
C14H11Cl2NO2  
296 6.02 
4.19x10
2
-2769 
x10
3
 
1.75-
3.35 
0.09-
0.11 
Monensin 
C36H62O11 
 
670 5.43 
6.21x10-
3.65x10
2
 
1.00-
3.12 
0.01-
356.9 
 
Table 2.2 Chemical properties of steroidal estrogens and selected pharmaceutical compounds 
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2.2.1 Entry of Endocrine Disrupting Chemicals and Pharmaceutically-active 
compounds to the aquatic environment 
 EDCs and PPCPs, as with many other emerging pollutants can be discharged to the 
aquatic environment from both point and non-point or diffuse sources. A point source has a 
clearly definable point of entry into the aquatic systems, while a non-point or diffuse source 
has an unknown point of entry. As far as EDCs and PPCPs are concerned, the major point 
sources are effluent discharges from STW, industrial wastewater, and landfill leachate, 
while diffuse sources are diverse including surface runoff from agricultural land and 
atmospheric deposition
1
.
 
Of all the sources, STW has received the greatest attention 
worldwide. This emphasis has several reasons, first the estrogenic effects of EDCs (fish 
feminisation) was first discovered in fish population downstream of STW effluents, a trend 
since confirmed globally. Secondly, levels of EDCs and PPCPs in wastewater tend to be 
higher than those in surface waters, and are hence more easily detected. Moreover, water 
companies are under increasing pressure to improve the efficiency of EDC removal, to 
meet national and global regulations for EDCs, hence it is in their interest to monitor 
regularly the EDC concentrations in wastewater samples. 
EDCs in STWs have been previously [14], it was found that the removal efficiency 
of EDCs is highly dependent on the properties of individual compounds, and the 
technology being used. For example, 90% of PCBs could be removed by biofiltration, 
whilst 70% of E2 and EE2 could be removed by filtration. Most STW have two stages of 
treatment, primary sedimentation followed by secondary treatment. Some EDCs such as 
alkylphenols could be removed significantly in primary treatment, by adsorption to 
sediments. But for the most potent EDCs such as E1, E2 and EE2, their removal in primary 
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treatment is very limited as they do not interact strongly with sediments. Hence secondary 
treatment plays a critical role in removing them from wastewater. Of the different 
secondary treatment technologies, activated sludge process is the most versatile and most 
widely used. The performance of activated sludge process in the removal of EDCs has been 
reviewed by Johnson and Sumpter (2001), who suggested the process can consistently 
remove over 85% of E2 and EE2, although the removal of E1 is more limited and variable. 
 Both EDCs and pharmaceutical residues have been monitored previously through 
the different stages of treatment in a STW in the UK [15-16], these studies found that the 
most abundant EDC was bisphenol A which ranged from 298 to 1010 ng L
-1
 in the influent. 
This is expected due to the wide use of bisphenol A as a monomer for the production of 
polycarbonate and epoxy resins, unsaturated polyester-styrene resins and flame 
retardants
41,42
 The concentrations of other compounds in the influent varied from 14-78 ng 
L
-1
 for 4-tert-octylphenol, 87-321 ng L
-1
 for 4-nonylphenol, 20-60 ng L
-1
 for E1, 26-51 ng 
L
-1
 for E2, < 0.8-10 ng L
-1
 for EE2, and 24-33 ng L
-1
 for hydroxyestrone, respectively. 
EDCs were not significantly removed by primary sedimentation, especially natural 
estrogens, indicating that EDCs were weakly binding to particles contained in wastewater. 
This is expected, as they are weakly hydrophobic organic pollutants
43
, as demonstrated by 
their small Kow values (Table 2.2). When extracting the coarse particles collected by 
filtration through 20-μm filter discs in situ, it has been found that the particle fraction 
contained less than 0.1 ng L
-1
 of E2 [17]. Similarly, other another study found no evidence 
that estrogenic compounds were adsorbed on the particles collected by filtration through 
0.2-μm filter [18]. Not surprisingly, the concentrations of selected EDCs were reduced 
substantially after biological filtration in an STW in Horsham, UK. Natural estrogens were 
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reduced to an average concentration of 17 ng L
-1
 for E1 and 16 ng L
-1
 for E2, respectively. 
For the other compounds, more than 50% reduction was achieved after the secondary 
treatment. From these data it clear that STW treatment technology is a significant factor in 
understanding the likely release of endocrine disrupting and pharmaceutical compounds 
into the aquatic environment. The work in this thesis examines further the role of new 
tertiary treatment technologies (such as activated carbon) compared to existing wastewater 
clean-up processes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 Flow diagram of a typical STW 
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The fact that all of the target EDCs were found in the effluent, e.g. 4-nonylphenol 
(6-36 ng L
-1
) and E1 (6-10 ng L
-1
), indicated that EDCs were not completely removed 
during the treatment processes. Based on the field data, removal efficiency defined as the 
net change of chemical concentrations between influent and effluent was calculated, which 
ranged from 59% for 4-nonylphenol to 100% for 4-tert-octylphenol. Overall, bisphenol A 
showed the highest removal efficiency (90-96%), as it is readily biodegraded. It has been 
suggested that technologies to remove NP are both expensive and to date, not 100% 
efficient [19]. With a range of chemical classes suspected to have endocrine-disrupting 
effects, each with a vast range of chemical properties and behaviors, the development of 
efficient removal technologies for all EDCs is a major challenge, which needs to be 
balanced with other costs, both financial and environmental. The disposal of pollutant-
containing sludge remains a major issue, and where removal technologies are „CO2 
intensive‟ they may contribute to other environmental degradation, such as the so-called 
anthropogenic climate change effect. 
In addition to STW, other sources of inputs include animal farming, aquaculture and 
spawning. It has been proposed [20] that the input of EDCs to aquatic systems by 
agriculture is likely to increase due to the increasing use of sludge and sludge-derived 
products as so-called value-added products (VAPs), such as pesticides and fertilizers.  
 
2.3 Endocrine Disrupting Chemicals (EDCs) 
2.3.1 Introduction 
Over the last two decades a variety of effects that are attributable to EDCs have been 
observed including changes in sperm counts, genital tract malformations, infertility and an 
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increased frequency of mammary, prostate and testicular tumours
 
[21-24]. EDCs are a very 
wide and diverse group having a multitude of action mechanisms on the affected 
organisms, including substances that mimic and/or antagonise the effects of hormones, alter 
the pattern of synthesis and metabolism of hormones, and modify hormone receptor levels
 
[25-27]. The UK Environment Agency (EA) has highlighted the seriousness of the problem 
as the range of substances that have been reported to cause endocrine disruption is 
extremely diverse and the list of potential suspects is rapidly growing
9
. Among the 
potential EDCs including steroids, alkylphenols, organochlorine pesticides, triazine 
herbicides, polychlorinated biphenyls and phthalate esters, three compounds, i.e. estrone 
(E1) and 17-estradiol (E2) both being natural hormone, and 17-ethynylestradiol (EE2, 
synthetic hormone) have been widely studied and shown to cause feminisation of fish
 
[28-
29]. Many of such compounds are classified as priority substances in the EU‟s Water 
Framework Directive (2000/60/EC). In terms of estrogenic activity, however, the most 
important EDCs are E1, E2 and EE2, as they are far more potent than other compounds 
such as bisphenol A or alkylphenols, and can cause fish feminisation at approximately the 
ng L
-1
 level
10,12
. Due to uncertainty in their impacts on terrestrial and aerial organisms as a 
result of lack of data, E1, E2 and EE2 are not yet included in the list of 146 substances with 
endocrine disruption classification; nevertheless, their feminisation effects in invertebrates 
and fish have been confirmed worldwide. 
2.3.2 The Endocrine System 
The endocrine system is essential to both plants and animals as it is responsible for the 
regulation of growth, reproduction, maintenance, homeostasis and metabolism, through the 
production of hormones with different functions
1
. Hormones are chemical messengers that 
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are secreted by endocrine cells into the bloodstream and other extracellular fluids, which go 
on to bind with specific receptors on a cell and thus communicate instructions.  
The endocrine system consists of a number of glands that produce hormones. These 
include: the pituitary gland, adrenal glands, thyroid glands, parathyroid glands, pancreas, 
ovaries, and testes. A number of other cells are also capable of producing hormones such as 
myocytes in the heart and epithelial cells in the stomach and intestines. These cells are part 
of what is often referred to as the „diffuse endocrine system‟.  
The normal function of endocrine system can be disrupted by the so called endocrine 
disrupting chemicals (EDCs), which interact with the hormone receptors, hence producing 
unnatural responses.  
2.3.3 Definition of EDCs 
According to the EU, an EDC are defined as “an exogenous substance or mixture that alters 
the function(s) of the endocrine system and consequently causes adverse health effects in 
an intact organism or its progeny, or (sub)populations”. A similar but more detailed 
definition was proposed by the US Environmental Protection Agency (EPA) as “an 
exogenous agent that interferes with the synthesis, secretion, transport, binding, action, or 
elimination of natural hormones in the body that are responsible for the maintenance of 
homeostasis, reproduction, development, and/or behaviour”. 
2.3.4 Implications of EDCs for human health and wildlife  
EDCs can operate as hormone mimics (agonistic response) and use the cell‟s receptors to 
inhibit or stimulate the normal cell response. This is exactly how a normal hormone works, 
therefore all hormones are agonists. They can also act as hormone blockers (antagonistic 
response). EDCs can also affect normal hormone synthesis as well as bring about the 
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Response 
removal of the hormone from the circulation. The processes of endocrine disruption are 
more succinctly demonstrated diagrammatically, as in figure 2.2. 
Figure 2.2 Principles of the action of endocrine disruption 
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also been shown that they can cause similar problems in insects [34], amphibians [35], 
reptiles [36] molluscs [37], [38] and even sponges [39].  
 
Birds are also at risk as was highlighted in the book Silent spring [40], which discussed the 
risk to the bird population by the organochlorine pesticide dichlorodiphenyltrichloroethane 
(DDT). This chemical caused an interference with calcium metabolism and so the birds‟ 
eggs became too thin to carry out reproduction. 
 
As for health risks to humans, there is considerable evidence that they have the potential to 
disrupt the endocrine system. For example, the use of diethylstilbestrol (DES) between 
1938 and 1971 as a treatment to help with pregnancy complications such as miscarriage and 
premature delivery, caused clear-cell adenocarcinoma of the vagina and cervix in daughters 
of the treated women [41]. The treated women also showed a slightly increased risk of 
developing breast cancer.  
Studies on male hamsters have shown that disruption to spermatogenesis can be caused by 
neonatal exposure to DES [42]. This is made more alarming with the realisation that DES is 
also capable of being passed to neonates via breast milk [43]. 
An hypothesis known as testicular dysgenesis syndrome (TDS) purports that 
cryptorchidism, hypospadias, impaired spermatogenesis and testicular cancer can all be 
attributed to disturbed prenatal testicular development [44]. TDS is thought to be related to 
either genetic or environmental factors. Although there have been studies of children whose 
parents were accidentally exposed to EDCs, human studies of these problems with regard to 
EDCs are impossible to undertake for ethical reasons. One study in particular [45] 
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examined the anogenital distance (AGD) in male children compared to nine phthalate 
monoester metabolites in prenatal urine samples. The results showed that exposure to 
phthalates at a concentration below that found in a quarter of American women, was 
enough to cause genital development irregularities that were consistent with phthalate 
induced incomplete virilization in rats. 
Although a causal relationship between human reproductive disorders and EDCs has not 
been established, there are some concerning trends in the ratio of male to female children 
being born and in the general sexual health of humans. A study of birth ratios in Denmark, 
the Netherlands, Canada and the United States between 1950 and 1998 [46], found that 
from the normal male proportion of births had declined. The change was very small but was 
statistically significantly and was repeated in all of the countries under study. For example, 
in Denmark it had dropped from 0.515 in 1950 to 0.513 in 1994 and in the Netherlands it 
had dropped from 0.516 to 0.513. They concluded that “reduced male proportion at birth 
should be viewed as a sentinel health event that may be linked to environmental factors".   
A study of the links between testicular cancer, low fertility and an excess of females 
compared to males among offspring [47] concluded that “specific agents that act prenatally 
to disrupt normal development and differentiation of the male reproductive organs may be 
particularly relevant, and that current hypotheses link testicular cancer risk to exposure of 
the male embryo to maternal or environmental estrogens". 
Wier et al [48] conducted a population based, case control study that looked at men from 
Ontario, Canada with confirmed primary malignant germ-cell testicular cancer. 
Questionnaires completed by the men‟s mothers concerning their use of prescription 
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hormones around the time of conception, gave evidence that exposure to maternal 
estrogenic hormones was associated with testicular germ-cell cancer risk. They also found 
that exposure to lower levels of maternal hormones appeared to decrease the cancer risk. 
2.3.5 Removal of EDCs by STWs 
It is generally accepted the most EDCs are discharged into the aquatic environment 
from the effluents of sewage treatment works (STW). Studies have found that the majority 
of cases of endocrine disruption occur at or near STW outfall sites
 
[49]. Other sources 
include animal agriculture, aquaculture and spawning fish [50]. It has also been shown that 
EDCs can have additive effects when more than one chemical is present [8][15][16]. 
Estrogenic hormones have been detected in influents and effluents of STW in many 
countries [10][17-19] surface water
 
[20-21], as well as drinking water [22]. Considering the 
widespread occurrence and potential impacts of EDCs, it is highly important to remove 
them before discharge. The current data suggest that wastewater treatment processes (e.g. 
activated sludge) have variable performance in removing EDCs. By comparing the influent 
and effluent estrogen concentrations, one study [19] concluded that the removal rates for E1 
and E2 were 87% and 61%, respectively. In a Brazilian STW, the observed removal rate for 
EE2 ranged from 64-78%. In Swedish STW, the average removal rate was 81% by 
activated sludge treatment and only 28% by solid supported bacterial treatment. It is 
therefore essential to install additional treatment processes after secondary treatment step, 
to ensure a more complete removal of such compounds. A typical STW involving primary, 
secondary and tertiary treatment is shown in Figure 2.1. 
2.3.6 Analysis of EDCs in water and wastewater samples 
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In order to minimise EDC impacts on human and wildlife health, an understanding of 
occurrence and behaviour their necessary.  Accurate, reliable and sensitive analysis of 
suspected EDCs in environmental water samples is a critical prerequisite for the reliable 
and routine monitoring of EDCs and EDC-fate studies. The determination of EDCs in 
environmental water samples can be performed by different techniques, among which GC-
MS and LC-MS are the most widely used due to unrivalled sensitivity and selectivity and 
increasingly wide access. There have been previous reviews on the analysis of EDCs by 
MS (e.g. [51]). EDC analysis involves many interrelated steps, as shown in Figure 2.2. 
During sampling, typically 1-2 L of water or wastewater samples is taken and filtered as 
soon as possible to remove particles. The filtered water samples are then spiked with 
appropriate internal standards (typically isotope-labelled analogues of the target 
compounds), followed by concentration using solid-phase extraction (SPE) cartridges or 
discs. The EDCs adsorbed on SPE are then eluted by using a small volume of organic 
solvent (e.g. methanol), which are purified (especially important for sewage influent 
samples) and further concentrated under N2 blow down. The final sample extracts are 
analysed by GC-MS or GC-MS/MS after derivatisation, or analysed by LC-MS or LC-
MS/MS without further treatment. There have been many studies comparing the 
performance of different SPE products in concentrating EDCs from water and wastewater 
samples. Liu et al. (2004) compared the recovery of EDCs in nine different SPE cartridges, 
and concluded that the Oasis SPE cartridges from Waters generated the highest recovery 
for E1, E2, EE2, 16-hydroxyestrone, bisphenol A, 4-nonylphenol, and 4-tert-octylphenol. 
The finding was later confirmed by Zhang et al. (2006). For solid samples such as 
sediments and sewage sludge, they tend to be freeze-dried first before extraction by various 
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techniques, one of which is the microwave-assisted extraction. Sample extracts are then 
analysed in the same way as for water samples.  
Figure 2.2 Typical sample processing steps for chemical analysis 
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of trimethylsilyl (TMS) and t-butyldimethylsily (TBS) derivatives, respectively. Catalysts 
such as trimethylchlorosilane (TMCS), trimethylsilylimidazole (TMSI) and tert-
butyldimethylsilylchlorosilane (TBCS) are widely used to enhance derivatisation [28,29]. 
From the evaluation of a number of similar reagents for detecting both natural and synthetic 
estrogens by GC-MS, Ding and Chiang (2003) concluded that BSTFA with 1% TMCS 
operating at 70
o
C for 30 min was the best derivatisation reagent. However, other 
researchers suggest a problem with the use of BSTFA or MTBSTFA to derivatise E1 and 
EE2, as the resulting TMS and TBS derivatives of EE2 could partially be converted to their 
respective E1 derivatives [28][29]. Zhang et al. (2006) also confirmed that in the absence of 
pyridine, EE2 can be converted to three different products including TMS-E1, mono-TMS-
EE2 and di-TMS-EE2, hence producing erroneous results. It is therefore critical that both 
pyridine and BSTFA are used simultaneously during derivatisation of EDCs and 
compounds of similar structures. 
More recently, the bench-top tandem MS has become more widely available and hence 
widely used, due to the advantages of tandem MS being more selective. It has been shown 
that GC-MS/MS produces increased selectivity and sensitivity compared to GC-MS [30], 
with limits of detection ranging from 0.01 to 0.49 ng L
-1
 in water samples. A more recent 
and increasingly popular technique has been the LC-MS/MS, which does not require 
sample derivatisation. In chapter 4, the performance of GC-MS, GC-MS/MS and LC-
MS/MS in the analysis of steroidal estrogens, and it is concluded that the GC-MS technique 
is the simplest to operate, but fails to detect the estrogens at the lower-end of 
environmentally relevant concentrations. The tandem MS techniques are more selective 
than MS, and therefore able to detect lower concentration levels of the three steroidal 
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estrogens of interest. However, it was observed that the LC-MS/MS technique is more 
susceptible to matrix interferences for the analysis of samples, resulting in a reduction of 
the signal-to-noise ratio and a subsequent reduction in reliability and stability compared to 
GC-MS/MS. With the GC-MS-MS technique offering increased selectivity, the lowest 
limits of detection, and no false positive identification, it is recommended to be the 
preferred analytical technique for routine analysis of estrogens in environmental water 
samples. However, the need for sample derivatisation is a major disadvantage for GC-
MS/MS, so overcoming the matrix effect will make LC-MS/MS more reliable in compound 
identification and hence more attractive, particularly with recent developments such as 
ultra-performance liquid chromatography (UPLC) and improved mass spectrometric 
techniques, such as time of flight (TOF) which provide better selectivity than MS/MS, but 
its sensitivity can be inferior to the latter [52]. 
As far as water sampling is concerned, two approaches have been used, spot and 
passive sampling. Spot sampling has long been the preferred method for obtaining 
environmental water samples for chemical analysis, due to the ease in which samples can 
be collected, however such samples only yield an instantaneous measurement, and thus 
suffer from high uncertainty from short- and long-term concentration variability. 
Subsequently, there has been recent growth in the use of passive sampling techniques 
allowing for composite sample collection, which can be time and flow weighted. These 
devices typically employ a sorbent phase encased between two microporous membranes, 
and can easily be deployed for a range of time periods as required, and may be used to 
simulate the bioconcentration of pollutants by aquatic organisms. By choosing appropriate 
sorbent material, passive sampling can be engineered to target for the measurement of 
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specific classes of pollutants, e.g. Oasis sorbent (Waters) is particularly suited for EDCs 
while C18 sorbent for non-polar compounds such as triazine herbicides and PCBs. One of 
the limitations, though, is the need to obtain sampling rates of the target pollutants in the 
field, which can vary due to different hydrodynamics, sediment load, pollution source 
strength and biofouling. 
In addition, biological-based essays are also widely employed for the measurement of 
EDCs in environmental samples, on which an extensive review was recently published 
[33]. These biologically directed methods include whole organism assays, cellular 
bioassays, and non-cellular assays, among which cellular bioassays such as yeast estrogen 
screen (YES) and yeast anti-androgen assay (YAS) are perhaps the most widely used. YES 
was developed by Routledge and Sumpter (1996)[34], by engineering YES cells with a 
human estrogen receptor gene which then binds to an estrogen response element regulated-
expression plasmid (lac-Z) coded to express –galactosidase. YES provides a measure of 
the so-called E2 equivalent (EEQ) which equates to the combined additive estrogenicity in 
the presence of various estrogenic chemicals. Whether a correlation exists between YES-
generated value and EEQ derived from chemical measurement is yet to be established. 
Another widely used bioassay is the enzyme-linked immunosorbent assay (ELISA). 
Immunoassays show attractive features for organic trace analysis due to the fact that they 
require little sample pre-treatment, exhibit high sensitivity, and are inexpensive in 
comparison to the instrumental analysis such as GC-MS and LC-MS. A considerable 
number of ELISA kits have been developed, which are commercially available and used for 
the analysis of a range of contaminants in water samples, such as estrogenic compounds, 
surfactants and pesticides, and more recently pharmaceuticals, and personal care products. 
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2.3.7 Occurrence, transport and transformation of EDCs in rivers 
EDCs from different sources eventually find their way into natural waters such as 
rivers, streams, lakes, groundwater, estuaries and sea, in the form of dissolved compounds 
as well as in association with sediments. EDC monitoring tends to be focused in the 
dissolved phase due to more frequent detection and direct impact of EDCs on fish.  
In the last two decades, numerous publications have reported results of surveys of 
the most potent EDCs; the natural steroidal estrogens E1 and E2, and the synthetic EE2. 
These three compounds have been found in natural river systems at concentrations ranging 
from below the limit of detection to 112 ng L
-1
, below the limit of detection to 200 ng L
-1
 
and below the limit of detection to 50 ng L
-1
 for E1, E2, EE2 respectively. It is suspected 
that the highest concentrations occur where raw or poorly treated sewage is discharged 
directly into water streams and rivers. A more complete distribution dataset is shown in 
Table 2, which shows the focus of environmental monitoring has been in river 
environments, with less attention to other environmental waters, hence the sparse data for 
lakes, seawater, estuarine and groundwater environments. Globally, whilst there is a large 
variability in the ranges of concentrations being reported in each country, the variability 
between countries appears to be less significant. There does however appear to be greater 
variability in reported concentrations in Chinese rivers, potentially due to the rapid 
industrial growth in some regions, although this may also be at least partly attributable to 
the larger number of separate studies undertaken in comparison to elsewhere.  
Natural processes in river environments which may remove steroidal estrogens from 
the aquatic phase include volatilisation, degradation and sorption to solid phases. It has 
been suggested that degradation is primarily through the biotic route and that under abiotic 
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conditions estrogen levels remained relatively constant [47]. In the presence of common 
bacteria and algae, however, a rapid reduction of estrogenicity is observed, where the 
biotransformation of E2 to the less potent E1 has been shown to follow first-order kinetics 
with a half-life of 0.2-9 days compared to >10 days under ideal-laboratory conditions.  
Several publications have attempted to estimate the partitioning of these steroidal 
estrogens in different environmental phases. Predominately, these have focussed on the 
dissolved aqueous phase and the sediment phase. In laboratory conditions, it has was found 
that sorption E1 and E2 to sediment was slow and small, reaching equilibrium in 50 days, 
compared to a half life of 5 days in ideal laboratory conditions
 
and found that the presence 
of surfactants in effluents reduced sorption [48]. Another study [50] found only a few 
sediment samples contained EDC concentrations exceeding their quantification limits. 
Nevertheless, several publications have reported significant concentrations of these 
steroidal estrogens in river sediments. One study [51] consistently detected E1 is sediments 
collected from Tokyo Bay in the range of 0.08-3.60 ng g
-1
, whilst E2 was detected in only 7 
of 20 sampling stations, and EE2 was not detected at any of the stations. In the UK, it has 
been shown that of these three steroidal estrogens, E1 was the predominantly detected 
compound in surface sediments and was found at peak concentrations in sediments at 
approximately 15 cm depth, at the alluvium/clay interface [52], suggesting vertical 
transport of these compounds should be further explored, owing to the risk of release in 
storm or high-flow events. A significant correlation between the sorption and retention of 
steroidal estrogens by sediment and its organic carbon content has also been observed, 
where sorption increases with increasing organic carbon content [46][53]. It has further 
been observed [54] that in sediments downstream of three sewage effluents in the USA that 
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E2 was more readily degraded by microbial activity in sediments than E1, and that the 
degradation of E2 in sediments did not involve conversion to E1, and that microbial 
degradation was significantly stimulated for E2, but unchanged for E1, downstream of 
effluent, compared to upstream sediment samples, indicating that sewage effluents may 
enhance microbial degradation of E2 in receiving waters.  
In addition to the dissolved and sediment phases, natural colloids have been 
suggested as a potential sink of steroidal estrogens, where these compounds readily adsorb 
to abundant natural colloids, a process enhanced by the presence of surfactants [55][56], 
which may alter the persistence of these compounds in the environment. 
Alkylphenols, such as NP, OP and BPA have also been reported in natural rivers, 
albeit at concentrations significantly lower recently, than in the past, due to the phasing out 
of these compounds following EU legislation introduced in 2003 (EU directive 
2003/53/EG) restricting their use, with other countries including Japan, and Canada 
subsequently introducing similar legislation. Reported concentrations of these three 
alkylphenols in the Glatt River, a tributary of the Reine, since the introduction of the EU 
legislation, to be an order of magnitude lower than those measured in 1984 [57]. Indeed, 
other studies in Germany have found that significant reductions of NP occurred between 
2003 and 2005, but observed that concentrations in rivers exceeded those attributable to 
sewage effluent, suggesting additional sources [58]. However, other studies suggest that 
alkylphenols tend to associate with sediments rather than remain in the aqueous phase [59].  
Furthermore, concentrations of NP isomers as high as 4.1 µg L
-1
 in the aqueous phase and 
1mg kg
-1
 in sediments still occur in the natural environment despite the introduction of 
legislation to restrict their use, have been reported [60].  More positively, concentrations of 
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BPA are generally below predicted-no effect concentrations and concentrations of OP are 
also generally much lower than concentrations of NP. BPA, NP and OP are readily 
degraded by biological and photo-oxidation pathways [59]. 
There are some 127 pesticides recognised to have endocrine-disrupting effects. Of 
these, several are believed to be particularly pertinent due to their presence at high 
concentrations, despite their low estrogenic potency. The use of pesticides for agricultural 
purposes in the UK has grown from ~22,000 tonnes to more than 35,000 tonnes in 1998, 
although usage has declined slightly since, this still reflects a usage of 2-2.5 kg ha
-1
 of 
agricultural land. Pesticide use in central and eastern Europe was historically much higher, 
but reduced significantly (from ~2kg Ha
-1
 in 1989 to <1 kg Ha
-1
 in 1997) following the 
collapse of the Soviet Union, although in these countries, use is now increasing. Of these 
volumes, approximately 10% is estimated to be those which have known endocrine 
disrupting properties. Of these, use has generally declined, as for example DDT and lindane 
have been phased out. However, use of the 10 most popular endocrine disrupting pesticides 
has maintained relatively constant. Globally, pesticide-use for agriculture is widely 
documented in developed countries, as it is usually a legal requirement. However, outside 
of agriculture, there is no such requirement, and so data concerning non-agricultural use is 
scarce, with Local Authorities believed to be the predominant non-agricultural user of 
pesticides. Despite the high volume of use of ED pesticides, little research has been 
undertaken to quantify the impact of these compounds on the estrogenicity of receiving 
waters, as such, little is known about the pathways of these compounds into the aquatic 
environment, with the exception of OP and NP which are discussed previously. Of 
widespread concern is the risk of human exposure to pesticides, although their endocrine 
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disrupting properties are seldom taken into account in legislative matters, despite a plethora 
of research highlighting the potential for deleterious ED effects of pesticides in humans and 
aquatic organisms [61].  
Phytoestrogens are a relatively under-researched area of environmental endocrine 
disruption. Although phytoestrogens are naturally-occuring in the environment, their 
excretion in human urine at concentrations as much as 1000-fold higher than E1 or E2, and 
with only partial removal of these compounds by sewage treatment causes inflated 
concentrations in receiving river waters. As a result of their presence at high 
concentrations, despite their low potency, it is believed that phytoestrogens may contribute 
significantly to their estrogenic activity of river waters – and may contribute as much as 5% 
of the estrogenic activity of sewage effluent [62].  
2.3.8 Biological implications and risk assessment 
Although EDCs have been shown to have deleterious effects on aquatic organisms in 
laboratory experiments, whether or not they occur in the environment at concentrations 
sufficient to cause harm to fish populations remains unclear. Indeed, a recent review [60] 
concluded that whilst EDCs in the aquatic environment have the potential to impact on the 
reproductive health of various fish species, there is little evidence to suggest that there is 
any subsequent implications for fish populations, and suggest that there is a need for a 
reliable, in-situ indicator of such population-level impacts, and as such, the use of 
vitollogenin induction in males is insufficient, which has been found not to be a reliable 
indicator of endocrine disruption in some fish species [62]   
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Concentrations of the most potent EDCs in rivers, are typically at very low 
concentrations (up to 66.2 ngL
-1
 for E1, 33.9 ngL
-1
  for E2, and 30.8 ngL
-1
 for EE2), 
nevertheless, it has been shown that E2 and EE2 can have implications for the reproductive 
health of fish species at approximately 1 ngL
-1
, excluding the potential for synergistic 
modes of action
10,12
. Although far less potent, phenolic and pesticide endocrine-disruptors 
are often found at much higher concentrations (e.g. up to 14662ngL
-1 
for NP) and with 127 
widely-used endocrine disrupting pesticides there is potential that the combined 
implications of these mixtures may pose a greater risk to aquatic, and indeed, human 
health
61
. Such a risk may be enhanced by the presence of other stress-causing conditions, 
such as the presence of other pollutants, climate change or the presence of other diseases 
amongst a population.  
Although the risks associated with EDCs primarily focus on aquatic wildlife, there may 
also be a significant risk to humans, where endocrine-disruption has been linked to human 
cancers [63], and numerous exposure pathways have been identified [64], some of which 
are highlighted in Figure 2.3. It would appear that the risk to humans from EDCs is 
exacerbated for those most likely to be exposed to such chemicals, such as those working in 
an agricultural or factory environment, where the use of EDCs may be commonplace. The 
risk is further enhanced in more vulnerable groups, which includes unborn children, young 
children, and those who are genetically susceptible to endocrine disrupting effects.  
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Figure 2.3 Routes of human exposure to EDCs  
 
Conclusions 
EDCs have been shown to be present in a variety of aquatic environments globally, 
primarily due to their incomplete removal from wastewaters, with the effluents of STW 
being the predominant source. Research has focussed on river environments, because these 
are often the receiving waters of sewage effluents, and because of the lower dilution-factor 
compared to seawater. Nevertheless, it is apparent from the limited data that in enclosed 
seas and harbours, there is the potential for EDC compounds to accumulate, and further 
attention should be paid to these, and sensitive estuarine environments. The impact of 
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sorption of EDCs to sediments may potentially play an important role in their transport, and 
it is suggested [65] that monitoring programmes include analyses of sediment. Despite their 
widespread use and presence in the environment, the impact of less potent EDCs, such as 
pesticides and phytoestrogens is poorly understood, as monitoring programmes tend to 
focus on the more-potent steroidal estrogens and less frequently, phenolic EDCs.  
The overall risk to the population of aquatic species remains unclear. Although 
laboratory investigations have shown the potential for EDCs to pose a significant threat to 
fish reproductive health [66], there continues to be a lack of conclusive evidence from field 
observations. Similarly, the risk to human health remains un-quantified, despite 
associations with deleterious effects.  
2.4 Pharmaceutical and Personal Care Products (PPCPs) 
The term PPCP refers to any product used for personal health or cosmetic purposes, or by 
farmers to improve the health and growth of their livestock. They include: prescription and 
over the counter pharmaceuticals, illicit drugs, fragrances, cosmetics, veterinary drugs,  
diagnostic agents, sun-screen products and vitamins [67]. These drugs and products are 
designed with specific purposes in mind and in many cases are aimed at bringing about 
specific cellular responses. Although the levels of these chemicals found in the 
environment are generally very low, much lower than the prescribed dose, their continued 
introduction into the environment confers upon river biota continual multi-generational 
exposure. The health risks associated with the continual, low dose exposure to a large 
mixture of chemicals are still not completely understood. It may be that there are low dose 
effects occurring to river wildlife that as yet remain undetected.  
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The nine PPCPs used in this work are amongst the most commonly studied of this group of 
chemicals [68] and with an „in-house‟ LC-ESI-MS/MS analytical method [69], internal 
standards and the pure chemicals all readily available in our laboratory, the choice of 
analytes was relatively simple.  
Literature regarding the fate and transport of some of these chemicals is very limited. The 
physico-chemical properties of the nine PPCPs used in this study can be seen in Table 2.2. 
2.4.1 Propranolol  
Until recently, this beta-blocker was a first-line treatment for hypertension in the UK. Since 
then it has been downgraded to fourth-line, partly because it performs less well than other 
drugs but also due to increasing evidence that commonly used beta-blockers have an 
unacceptable risk of provoking type 2 diabetes. Propranolol is also used to treat angina and 
essential tremors where it is prescribed at 120 - 320 mg daily in divided doses. The drug is 
also used to treat tachyarrhthmia, anxiety and hypertension at the dosage of 10 - 40 mg, 3 - 
4 times daily. Propranolol hydrochloride is a white, odourless crystalline powder 
Robinson et al [70] found that 11 – 68 % of propranolol was removed by photodegradation 
in US rivers and predicted that up to 27 % could be removed in the River Aire, UK, during 
the summer. They concluded that phototransformation was the most important process in 
the attenuation of propranolol (and other pharmaceuticals that partition to the water phase) 
and that the effect of this process would be most effective in long, shallow rivers with low 
flow-rate and low turbidity.  
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Robinson et al [70] showed that 80 % removal of propranolol could be brought about by 
activated sludge in 30 days, although they were not able to say whether this was caused by 
adsorption to the sludge, or by biodegradation. 
2.4.2 Sulfamethoxazole  
Sulfamethoxazole is a bacteriostatic antibiotic most often used in combination with the 
drug trimethoprim, also a bacteriostatic antibiotic, in a 5:1 ratio. It prevents the formation 
of dihydrofolic acid (Vitamin B9), which is a necessary requisite for bacterial cell division. 
The drug is used against susceptible forms of Streptococcus, Staphylococcus aureus and 
Escherichia col and urinary tract infections [71]. Sulfamethoxazole enters the STW in 
metabolized form as N4-acetyl-sulfamethoxazole, which can be cleaved by bacteria, 
converted back to the original compound, and passed into the river system via the sewage 
outfall [147]. Zhou et al [72] found that the removal rates (RR) of this chemical varied 
between 52.7 and 82.3 % in three UK STWs (Scaynes Hill, East Sussex, Manor Farm 
Road, Berkshire and Basingstoke, Hampshire). 
Due to its Log Kow of 0.89 [1], and an estimated Koc of 72 [74], sulfamethoxazole is 
expected to have high mobility in soils. With a pKa of 5.5 it should also partially exist in 
the environment in the anionic form. Anions do not adsorb any more strongly to soils 
containing organic carbon and clay than their neutral counterparts [75], which again 
indicates the likelihood of high mobility in soil.  
In general, sulfonamide antimicrobials are not readily biodegraded and persist in soils [76] 
and even STWs. In a closed bottle experiment containing a sewage inoculum from a 
German STW,  Al-Ahmad et al found that sulfamethoxazole was not degraded at all [77]. 
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Another closed bottle experiment found a theoretical oxygen demand of 2 and 4 % after 14 
and 28 days, respectively. The cut-off for indicating biodegradability is 60 %, so this again 
categorizes sulfamethoxazole as non-biodegradable [78]. Boxall et al, using the OECD 301 
D test (closed bottle test) observed no biodegradation at all after 40 days [79]. Lam et al 
[80] found no difference in the t½ of sulfamethoxazole in sunlight-exposed pond water and 
autoclaved pond water. This is evidence that photodegradation is an important 
environmental fate process for sulfamethoxazole. The same group also found that in aquatic 
outdoor field microcosms, with concentrations of: 0.31, 6.31, 19, and 182.78 ug/L the 
resulting average field half-lives were: 18.7, 19.4, 17.5 and 20.3 days, respectively. 
2.4.3 Mebeverine  
Often sold under the brand name of Fybogel this compound is an antispasmodic used to 
relieve cramps or spasms of the stomach and intestines which is particularly useful in 
treating irritable bowel syndrome [81]. Mebeverine is available as mebeverine 
hydrochloride in 100 mg and 135 mg tablets, in 10 mg/mL oral liquid form and as a 200 mg 
slow release preparation. Reported side effects are generally limited to inflammation or 
reddening of the skin or an itchy rash. 
2.4.4 Carbamazepine  
This is a mood stabiliser and anti-convulsant used to treat bipolar disorder, schizophrenia, 
trigeminal neuralgia and epilepsy. It was first marketed in 1962 and has been used in the 
UK since 1965. Carbamazepine can render certain birth control pills ineffective because it 
is an enzyme inducer of the cytochrome P450 system, which is instrumental in 
metabolising the contraceptive. Reported side effects can include: blurred vision, temporary 
loss of blood platelets and even cardiac arrhythmias. 
51 
 
Only 1 – 2 % of carbamazapine is excreted by the body, but the excreted glucuronide 
conjugates of this chemical can be cleaved by sewage bacteria, thus increasing its 
concentration in sewage outfall [82]. Carbamazapine has shown poor RR from STWs [83] 
[84] [85] and does not appear to adsorb onto sludge [86]. This seems to be confirmed by the 
high concentrations of this chemical, often in the range of several hundred  ηg/L, regularly 
found in surface waters [87] [69]. 
Castiglioni et al [88] studied the seasonal variability in RR of pharmaceuticals through 
STWs and found that there was no difference between winter and summer RR for 
carbamazapine, indicating that this chemical is not removed by photodegradation and that 
temperature has no effect on removal. This is in contrast to the NSAID ibuprofen (also 
studied in that work), which showed a median winter RR of 38 % and a summer RR of 93 
%.  
Nakada et al [89] looked at the removal of carbamazapine during activated sludge 
treatment and found that only 50 % was removed, which again, indicates the high 
persistence of this chemical. This result is very similar to those found by Zhou et al [73], 
who found that the RR for carbamazepine in three STWs varied between 43 and 54 %, no 
matter which treatment process was used.  
Treibskorm et al [81] looked at the cytological effects of pharmaceuticals on freshwater 
fish (Rainbow Trout (Oncorhynchus mykiss) and Common Carp (Cyprinus carpio)) and 
determined that the lowest observed effect concentration (LOEC) of carbamazepine was 1 
ug/L. This LOEC is still far higher than the highest concentration found in the River Ouse, 
UK (554 ηg/L) during this study. 
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2.4.5 Indomethacine  
A non-steroidal anti-inflammatory drug (NSAID) which by the inhibition of prostglandins 
is able to reduce fever, pain, swelling and stiffness. The compound was discovered in 1963 
and was first approved for use in the USA in 1965. Adverse effects can include: peptic 
ulcers, dyspepsia, diarrhoea and also lithium retention in patients prescribed lithium. 
Zhou et al [73] found that the RR of indomethacine varied between 60.8 and 88.7 % in 
three UK STWs. At Scaynes Hill STW, 24 % was removed by primary sedimentation 
(humus tank) and a further 26 % was removed when passed through a lagoon. In total, the 
STW at Scaynes Hill, East Sussex, removed 61 % of the indomethacine present in the raw 
influent. 
2.4.6 Diclofenac  
Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) taken to reduce 
inflammation, and, as an analgesic, is used to reduce pain in conditions such as arthritis. 
Diclofenac use in cattle has led to a huge decline in the vulture population on the Indian 
subcontinent, with > 95 % of birds succumbing in some areas. That equates to 10‟s of 
millions of birds. Vultures eat the carcasses of cattle and other domesticated animals that 
have been administered with veterinary diclofenac and are poisoned by the accumulated 
chemical. Oaks et al showed that death is due to renal failure, a known side-effect of 
diclofenac, which leads to high levels of uric acid in the blood (hyperuricaemia) and 
visceral gout [90].  
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Contradictory results for diclofenac removal during conventional wastewater treatment 
have been reported in the literature. In some STWs, attenuation of 50 – 70 % has been 
reported [82] [84] [88] [91]. By contrast, many studies showed conventional treatment had 
extremely low efficiency (10 – 30 % removal) [87] [92] [93] [94]. Radjenovic et al [158] 
found that a membrane bioreactor used during the sewage treatment process was able to 
remove up to 90 % of diclofenac, while EPISUITE predicts an RR from STWs of 56 %. 
Gröning et al [95] investigated the ability of sediments in the water column to remove this 
chemical and found that they were capable of removing up to 94 %. which, in addition to a 
very low BCF of 3.162 L/kg wet-wt predicted by EPISUITE, would seem to indicate that 
diclofenac has low persistency in the aquatic environment. 
2.4.7 Meclofenamic acid  
A white, crystalline powder that is practically insoluble in water, meclofenamic acid is 
another potent inhibitor of prostglandins that is generally used in veterinary medicine for 
the relief of pain and inflammation, especially that associated with arthritis. 
There is very little in the scientific literature regarding the fate and transport of this 
chemical. However, the United States Geological Survey (USGS) EPISUITE software 
predicts that this chemical will have an RR in STWs of 92 %, with 91 % of this removed 
via sorption to sludge. It also predicts a low potential BCF of 56.23 L/kg wet-wt.  
2.4.8 Tamoxifen  
A selective estrogen receptor modulator that is used in the treatment of estrogen receptor 
(ER) positive breast cancer in pre and post menopausal women [96]. Dose is 10 - 40 mg/d 
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taken orally during days 3 - 7 of the women‟s menstrual cycle. The major excretory route is 
via the bile, with less than 1 % of the dose excreted in the urine.  
 
Common side effects include: fatigue, nausea, hot flushes, change in menstruation 
regularity or even cessation, possible harmful effects to a developing foetus and blood 
clots. There also seems to be correlation between long-term tamoxifen administration and 
endometrical proliferation [97]. The drug was first approved by the FDA in 1977, but in 
April 2006 it was announced that the drug raloxifene was just as effective but with fewer 
side effects.  
 
Retinal damage and keratitis have been reported in patients after large cumulative doses of 
tamoxifen, generally over 180 mg/d for more than 1 year [97], though sometimes with 
smaller doses [98].   
 
There is very little in the literature regarding the environmental fate of this chemical. 
Limited data suggests that tamoxifen has an elimination t½ of about 5 - 7 days (range 3 - 21 
days), with the elimination t½ of N-desmethyltamoxifen, the major metabolite estimated to 
be 9 - 14 days [99]. 
2.4.9 Thioridazine  
An anti-psychotic prescription drug widely used for 30 years to treat schizophrenia, anxiety 
and psychosis. It has some serious potential side effects, which include: cardiotoxicity, 
retinopathy, akathisia and a potentially fatal neurological disorder, neuroleptic malignant 
syndrome. 
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There is very little in the literature regarding the fate and transport of this chemical in the 
aquatic environment and as of 2001 there had not been any concerted environmental 
surveys of this drug undertaken [100]. The EPISUITE software estimates that thioridazine 
will have a high potential BCF of 3629 L/kg wet-wt, a Log Koc of 5.094 and t½ in a model 
river of 3.13 d [74].  The software also predicts the RR from an STW to be 91 %. 
Like meclofenamic acid, the only experimentally-based information regarding the fate of 
this chemical in the aquatic environment will be found in this thesis. 
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Chapter 3. Materials and Methods 
3.1 Introduction 
All of the techniques and methods used in this work are described in the following chapter. 
Section 3.2 describes the glassware preparation and the general quality-control procedures 
used in the laboratory, including a description the preparation of stock solutions and 
internal standards, as well as the grade of all solvents used.  
 
Sections 3.4 and 3.5 describe the methods used for the sampling and extraction of EDCs 
and PPCPs from environmental aqueous and sediment samples, respectively. 
 
The chromatographic techniques and methods employed in this work are described in 
section 3.6, while section 3.6 outlines all of the methods used to characterise the water and 
sediment samples.  
 
Section 3.7 describes the CFUF system and the methods used for: isolating aquatic colloids, 
and, partitioning EDCs and PPCPs between the colloidal and dissolved phases. 
Section 3.8 explains the methods used in the characterisation of colloids 
3.2 Quality control, Chemicals and standard solution 
3.2.1 Ultra-pure water 
The ultra-pure water used in the laboratory was supplied from a Maxima HPLC/LS water 
purification system (Elga Process Water, UK). This machine was custom-constructed as a 
hybrid of the Life Science and HPLC models to provide high purity water with low organic 
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carbon content. The ultra-pure water used in experiments had a quality of 18 MΩ/cm and 
an organic carbon content of < 3 ppb. The unit consisted of two replaceable filter packs 
used to remove ions via ion exchange resins, a hygienic, microfibre, 0.05 m ultra-filter 
pack, used to remove bacteria and small particulates, and a short-wavelength, UV, 
photochemical reactor to eliminate all remaining bacteria. Ultra-pure water was dispensed 
immediately prior to use, to avoid the possibility of contamination. 
3.2.2 Cleaning of glassware 
To reduce the risk of contamination of samples and standards, all glassware used in 
experimental work was cleaned; by soaking for a period of 24 hours in a solution of 5% 
Decon-90 (Fisher, UK), and subsequently, thoroughly rinsed with ultra-pure water. 
Immediately prior to use, all glassware was rinsed a minimum of three times with 
dichloromethane (DCM) to remove any residual organics, and allowed to air dry in a fume 
cupboard. Prior to use, glassware and other equipment where appropriate, was further 
cleaned by combustion in a furnace at 400ºC for 4 hours.  
3.2.3 Preparation of chemical standards 
For all mass spectrometric analyses, internal standards (IS) of the highest purity 
available were used to allow quantification. For analysis of steroidal estrogens, deuterated 
E1-d4, E2-d4, EE2-d4, (Qmx Laboratories Ltd., UK) and E2-d2 (Sigma Aldrich, UK) were 
prepared in a stock solution of 10 ηg/µL in methanol. For analysis of pharmaceutical 
compounds, diuron-d6 and 
13
C-phenacetin (Sigma Aldrich, UK) were again prepared in a 
stock solution of 10 ηg/µL in methanol. IS are expected to behave similarly to their non-
deuterated counterparts, but are distinguishable in mass spectrometric analyses. A known 
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volume of IS was added to a sample (at a concentration in the same order of magnitude 
expected for the analytes), and therefore any loss of analyte is corrected for by 
quantification relative to the appropriate IS.  
Additionally, compound mixes for both steroidal estrogens (E1, E2 and EE2) and 
pharmaceuticals (propranolol, sulfamethoxazole, meberverine, carbamazepine, 
indomethacine, diclofenac, and meclofenamic acid) were used by preparing stock solutions 
of 1000mg/L in methanol, which were further prepared into working solutions of 10ηg/μL. 
These standards were used for identification purposes in spectrometric analyses, in 
quantification of analytes, to quantify instrument stability, and method recoveries, and were 
of the highest purity commercially available.   
All standards and IS were stored in darkness at -18ºC, were weighed before and 
after use to quantify any losses due to evaporation and were regularly analyzed to ensure 
the compounds had not degraded. A small reduction in mass was presumed to be the result 
of evaporation of the methanol, and so additional methanol was added. Where a significant 
reduction of mass (>5%) was observed, the solution was discarded and replacement 
prepared. 
All solvents used throughout were of glass-distilled grade and were purchased from 
Rathburns, UK. Wherever samples were transferred between glass containers during 
experimentation, the surfaces were solvent rinsed three times and the rinsed solvent added 
to the sample extract to minimize losses due to sorption to the glass surfaces. 
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3.3 The sampling and sample preparation of aqueous samples for the analysis of 
steroidal estrogens and selected pharmaceutical compounds  
3.3.1 Collection of aqueous samples 
The aqueous „spot‟ samples were taken by an auto-sampler that opened at a depth of ~ 
0.5m so as to avoid the complex surface micro-layer. This device consisted of a weighted, 
steel cage that housed a Winchester bottle. The neck of the bottle was fitted with a spring-
loaded stopper that could be opened by pulling a rope when the bottle was submerged. The 
whole device was suspended on another rope and could be lowered from bridges or 
riverbanks. The samples (2.5 L) were collected in pre-cleaned, 2.5-L amber bottles, to 
which, 5 mL/L of 2 M sodium azide (Fisher, UK) was added as a broad-spectrum biocide. 
The bottles were capped, labelled and brought back to the laboratory where they were 
stored in the dark at 4
o
C until further preparation. 
Composite aqueous samples were collected into pre-cleaned 50L stainless-steel barrels. An 
automated pumping system was developed which employed a series of mechanical vacuum 
pumps each attached to a mains electricity supply via a timer switch. When activated, these 
pumps drew water through PTFE tubing, through an „overflow‟ bottle into the 50L barrel. 
The flow was calibrated to ensure the required volume of water was collected in the correct 
period of time, by altering the vacuum output of each pump.    
Samples were additionally collected using a passive sampling device. The design of the 
passive sampling device was similar to POCIS  except that the holder which supports both 
the diffusion-limiting membrane and sorbent and seals them in place was made of PTFE 
rather than stainless steel. The Oasis HLB sorbent (100 mg) from Waters Ltd, UK was 
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chosen because it sorbs a wider range of polar compounds than C18. The polyethersulfone 
(PES) membrane (0.1 m pore size) and polysulfone (PS) membrane (0.2 m pore size) 
were provided by Pall Gelman Sciences (VMR International, UK). PTFE used to construct 
the sampler was from Aquarius Plastics Ltd, UK. Peristaltic pumps (Watson Marlow 
401U/DM2) and tubes (0.5 mm x 1.6 mm and 3.2 mm x 1.6 mm) for controlling the flow-
through system were from Fisher, UK. 
3.3.2 Preparation of aqueous samples for extraction 
Upon returning to the laboratory, aqueous samples were filtered to remove suspended 
particulates through pre-ashed (400 
o
C for 4 h) Whatman GF/F filter papers (0.7 µm pore 
size), using a Büchner apparatus. The filtrates of samples were spiked with 100 ng of 
internal standards by micro-syringe, and were left for 1 h to allow mixing processes to take 
place, as in nature. 
3.3.3 Solid Phase Extraction  
SPE is a concentrative and purification step which implements a stationary solid 
phase, through which the analyte-containing aqueous sample is passed. The technique 
allows the analytes to be separated from their matrix, and such that the analytes are retained 
onto the stationary phase and the matrix passes through, or vice-versa. Typically, SPE is 
operated such that the analytes are retained on the stationary phase, in which case they are 
subsequently eluted and collected using an appropriate organic solvent.   
A wide range of SPE devices are available including cartridges, disks and well-
plates, in choosing which of these devices to use, the sample volume, matrix complexity 
and analyte characteristics are fundamental considerations. Typically, cartridges are used in 
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the chemical analysis of environmental pollutants as they allow for a high throughput of 
large-volume samples.  Additionally, SPE devices may be normal phase (NP), reverse 
phase (RP) or based on ion-exchange sorbent (Cation or Anion). NP sorbents are typically 
suitable for polar compounds, RP sorbents non-polar compounds, and cation-exchange and 
anion-exchange sorbents, bases and acids respectively. However, with the increasing use of 
SPE for multi-analyte analysis, a range of mixed mode, and balanced sorbents with both 
hydrophilic and lipophilic functional groups (retaining polar and non-polar compounds 
respectively) have become popular.  
 
Figure 3.1 An SPE cartridge 
Liu et al. (2003) and Zhang and Zhou (2007) compared a range of SPE cartridges 
for the extraction of EDCs and pharmaceutical compounds, and concluded that Oasis® 
HLB SPE cartridges offered the best recovery. Liu et al. (2003) and Zhang and Zhou 
Reservoir 
Frits 
Sorbent bed 
(Stationary phase) 
Tip 
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(2007) also investigated the efficacy of a range of solvents in the extraction of 
pharmaceutical and Endocrine-disrupting compounds (figure 3.2). For EDCs, Liu et al. 
(2003) concluded that Ethyl Acetate offered optimal recoveries, and thus opted to use that 
over the alternatives.  Zhang and Zhou (2007) however, concluded that methanol offered 
optimal recoveries, and is shown in figure 3.2, ethyl acetate gave particularly poor 
extractions, reporting 0% for some compounds. To allow simultaneous extraction of both 
EDCs and Pharmaceutical compounds, it was necessary to assess which solvent would give 
optimal recoveries across the range of compounds. As can be seen in figure 3.2, methanol 
clearly offers the most efficient recoveries for pharmaceutical compounds, and recoveries 
comparable to ethyl acetate for steroidal estrogens. 
Thus, Oasis® HLB SPE cartridges (Waters, UK) containing 200mg of 
Poly(divinylbenzene-co-N-vinylpyrrolidone) sorbent with a 6mL sample reservoir have 
been used in this work. The cartridges were conditioned with 2×5mL (10mL) Ethyl Acetate 
followed by 2×5mL (10mL) of methanol, followed by ultrapure water (3×5mL) at a rate of 
1–2mLmin−1. Subsequently, water samples were passed through at a flow rate of 5–
10mLmin−1. Afterwards the cartridges were dried for 30 min under full vacuum, to remove 
any residual water. The analytes  were then eluted to pre-cleaned 20mL glass vials from the 
sorbents with 10mL of methanol. The solvent was reduced to 0.1mL (for LC-MS/MS 
analyses) or to dryness under gentle N2 flow, and reconstituted according the derivitisation 
procedure for GC-MS(/MS) analyses. Reduced extracts were subsequently transferred to 
350µL fused insert vials and stored at -15ºC until analysis.   
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Figure 3.2 The effect of elution solvent on the SPE recoveries of each compound  
(adapted from Zhang and Zhou, 2007; and Liu et al., 2003) 
 
3.4 The sampling and sample preparation of sediment samples for the analysis of 
steroidal estrogens and selected pharmaceutical compounds 
3.4.1 Collection of environmental sediment samples 
Environmental sediment samples were collected using a stainless-steel Van Veen 
grab. Upon collection, the oxic fraction (the ~2cm at the top) was removed and discarded, 
as it is not representative of river sediment due to it being highly mobile and continuously 
undergoing disturbance and degradation by river fauna.  A sample of the sub-2cm fraction 
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was transferred into pre-cleaned 250ml glass jars, with a solvent-rinsed stainless-steel 
spoon.  
3.4.2 Preparation of sediment samples for extraction 
On return to the laboratory, the sediment samples were frozen, and subsequently 
lyophilised (by a Heto Powerdry PL3000 instrument for 4 days) to ensure only sediment-
bound residues are extracted, and because the presence of water can reduce the efficiency 
of solvent-based extraction, particularly where solvents that are immiscible with water are 
used.  After lypophilisation the samples were ground, homogenised and sieved to <500µm. 
3g Sub-samples were weighed into Teflon-lined extraction vessels and spiked with 100 ng 
of internal standards, were mixed with a pre-cleaned stainless-steel spatula and left for 
approximately 1.5 hours to allow sorption processes to occur. 2 g of copper granules 
(Sigma-Aldrich) were then added, to remove sulphurous compounds, followed by 25mL of 
methanol.  
A variety of techniques are appropriate for the extraction of organic contaminants in 
environmental sediments. Some of these techniques, such as soxhlet extraction have fallen 
out of favour due to the large volume of solvents required, which may pose a health risk to 
the operator and the significant amount of time required to process each sample. Moreover, 
soxhlet extraction at high temperatures is not suitable for the extraction of thermally 
unstable compounds, which may degrade during the extraction process and is also 
susceptible to co-extraction of matrix substances which may cause interference in 
subsequent analyses. Ultrasound-sonication („ultrasonication‟) has also been shown to be 
applicable for the extraction of a wide range of organic environmental pollutants with 
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recoveries comparable to soxhlet extraction whilst using a greatly-reduced volume of 
solvent and without the need for significant heating. However, ultrasonication and soxhlet 
extraction techniques typically have relatively poor reproducibility compared microwave-
assisted extraction. Ultrasonication baths in particular pose the additional issue of 
incomplete extraction where the bubbles caused by the ultrasound are unable to penetrate to 
the centre of samples, as is highlighted in figure 3.3, only the surface of the conical flask is 
in direct contact with the water bath, thus the central area of solvent undergoes reduced 
sonicative action. Ultrasonication probes (sonicators) alleviate these „sonication weakness‟ 
issues but are significantly more expensive to purchase and maintain, and can process only 
one sample at a time. Another risk with ultrasonication in baths arises where conical flasks 
are uncapped during the process, is that solvent (and with it the analyte) may evaporate. 
The alternative is to cap flasks which may violently de-cap due to the build up of pressure 
in the flask, causing a potential health risk to the operator.  
3.4.1 Microwave-assisted Solvent Extraction 
The rate of solvent-based extraction, as with any reaction, is dependent on the proportion of 
reactants that collide with sufficient energy; the so-called activation energy. Increasing 
temperature has long been used as a technique to enhance reaction rates, by both increasing 
the rate of such collisions, and also, and most importantly, increasing the energy of such 
collisions. Traditional heating techniques, such as conventional ovens, are inefficient as 
they rely on the heating of an entire surface and so require a large amount of energy and 
time. Moreover, they require a greater cooling time and less control over heating resulting 
in a lower sample throughput.  
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Microwaves act as high frequency electric fields and will generally heat any material 
containing mobile electric charges, such as polar molecules in a solvent or conducting ions 
in a solid. Polar solvents are heated as their component molecules are forced to rotate with 
the field and lose energy in collisions. Thus microwave-assisted extraction offers 
significant efficiency improvements over alternative techniques and was employed for the 
extraction of steroidal estrogens and pharmaceuticals from sediment samples. 
Thus, a microwave-accelerated solvent extraction method was optimised based upon work 
previously undertaken by Liu et al. (2004). The PTFE-lined, microwave extraction vessel 
and its contents were put into a tight-fitting pressure jacket designed to contain the vessel if 
it should explode under pressure. The jacket and vessel were then placed in a plastic frame 
and the lid of the vessel was held in place by a large screw (integral to the plastic frame) 
that was tightened down on top of it by spanner. 
The samples were then loaded into the MARS-X laboratory microwave accelerated 
extraction system (CEM Corp, USA) and heated to 110 
o
C for 15 minutes, with a 7 min 
ramp, at 200 psi. After cooling to room temperature for 1 h, the supernatant was decanted 
into 250 mL round bottomed flasks along with 3 x 15 mL sample rinses of MeOH. It was 
very important to make sure that the sediment had completely settled before the 
supernatants were decanted, otherwise SPE extraction would be slowed down considerably 
due to sediment particles blocking the SPE cartridge.  
The combined supernatants were reduced in volume to ~ 0.5 mL using a Büchi Rotavapor 
R-205 rotary evaporator. This used a Büchi Vac V-500, 230 v, 50 Hz pump, with a 
72 
 
pumping volume of 1.6 m
3
/h. The water bath was set at 40 
o
C and the sample flask was 
spun at 50 rpm. 
3.4.2 Clean-up of sediment samples 
Attempts at cleaning particularly „dirty‟ extracts using alumina/silica columns met with 
limited success. These extracts were often not cleaned suffciently and when the samples 
were blown down after extraction they remained very dark green in colour and would not 
dry completely. Analysis of these „dirty‟ extracts by GC-MS, GC-MS/MS and LC-MS/MS 
resulted in very noisy chromatograms with a high-level of background „noise‟ that were 
impossible to integrate. 
 
The clean-up process devised for this work entailed the addition of the 0.5 mL extracts to 
500 mL of ultra-pure water with 3 ultra-pure water rinses. The non-soluble components of 
the extracts, such as sand, clay and grit, settled to the bottom of the jar. The 500 mL 
samples were then passed through pre-conditioned Waters Oasis HLB cartridges at < 20 
mL/min, as described in section 3.3.3, The cartridge packing was then rinsed with 3 x 10 
mL of 5 % MeOH in pure water. This procedure result in much clearer extracts, removing 
much of the interfering organic matter. This afforded the integration of the resulting 
chromatograms.    
3.5 Mass Spectrometric analysis of sample extracts 
Sample extracts were analysed using a range of mass spectrometric techniques, 
including LC-MS/MS, GC-MS/MS and GC-MS. Primarily, analyses were performed on the 
tandem-mass spectrometer instruments; GC-MS/MS and LC-MS/MS.   
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3.5.1 The principles of gas and liquid chromatography 
Gas chromatography is a widely used technique that is able to determine the chemical 
make-up of a complex volatile mixture by separating its constituents on the basis of their 
molecular mass and polarity. This separation occurs in the capillary column, which consists 
of a long (10 – 100 m) thin (100 – 320 µm), hollow coiled tube made from fused silica. The 
column consists of a lining known as the stationary phase and a mobile phase or carrier gas 
such as helium that passes through the column. The sample constituents will all have a 
unique affinity to the stationary phase and the mobile phase. If the chemical has an affinity 
for the stationary phase then it will pass through the column slowly, if the affinity is for the 
mobile phase then it will pass through the column more quickly. The time that the 
individual chemical spends in the column is known as the retention time (RT) and if this is 
compared to the RT of a pure sample of the chemical, the identification of the chemical can 
be inferred.  
 
To analyse a sample by GC it must first be dissolved in a volatile solvent. A small amount 
(1 µL) is injected into a heated injection port where the sample is vaporised. The 
temperature of the injection port must therefore be above the boiling point of the least 
volatile component of the sample. The mobile phase then carries the vaporised sample 
through the column, which is itself contained in a thermostatically controlled oven. The 
partition of the different components is dependent on temperature, so the temperature of the 
oven starts off low and gradually increases so that all of the sample components are eluted. 
When it passes out of the end of the column the chemical passes through a detector (in this 
74 
 
case a mass spectrometer) and the data from this is plotted as a peak on a chromatogram via 
a computer.  
 
Sample injection can be carried out in two different modes; split or splitless. In split mode a 
vent is opened which carries away part of the sample to waste. The remaining fraction is 
transferred to the capillary column. This method prevents overloading of the column. In 
splitless mode the entire sample is transferred to the column and this is the preferred 
method for trace-level and quantitative analysis.  
 
Liquid chromatography works on a similar principle to gas chromatography, in that the 
basis for separation is on the individual chemical‟s affinity for either the stationary or the 
mobile phase. However, where as in gas chromatography, where vaporised extracts are 
carried by a gaseous mobile phase, extracts remain in the liquid phase and are carried by 
liquid solvents as the mobile phase, at high pressure (via a pump), through a densely-
packed separation column, which tend to be much shorter (50-150mm). In liquid 
chromatography, the selection of a suitable separation column and mobile phase solvents is 
vital, based on their polarity and the polarity of the chemicals to be analyzed.  
3.5.2 The principles of mass spectrometry and tandem mass spectrometry 
Separated components pass from the chromatograph and into the source chamber of 
the mass spectrometer via a transfer line that is heated to a high temperature. Inside the 
source chamber, a source of electrons is created by heating tungsten or rhenium wire until it 
is red hot. The negatively charged electrons released from the wire are attracted across a 
small gap to an ion trap which has a positive charge. The effluent from the chromatograph 
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Source MS1 MS2 
Collision 
cell 
Detector 
Every m
+
 m1
+
 Intact m1+ plus 
fragment ions 
Ion 
separation 
passes through this electron beam where the neutral analytes are hit by electrons with 
enough energy to remove an electron (or electrons) and thus cause ionisation and 
fragmentation.  
M + e → M+  + 2e     (ionisation) 
Mm + e
-
 →M+ + m + 2e-   (fragmentation) 
The charged particles are next repelled and attracted by charged lenses into a mass analyser 
(MS1) where the ionic species are separated according to their mass to charge ratio (m/z) by 
magnetic fields. In single-MS, these species would next pass onto a detector, which would 
be in the form of an electron multiplier. However, the fact that a sample containing 
compound A gives (for example) two characteristic ions (M-1)
+
 and (M-2)
+
 does not mean 
that the ions are definitely from A, as other compounds in the sample could quite possibly 
give (M-1)
+
 and (M-2)
+
. Tandem Mass Spectrometry goes further and queries whether (M-
2)
+
 comes from the decomposition of M
+
 in the mass spectrometer. It does this by 
separating out (M-1)
+
  and passing it from MS1 into the collision cell where an inert 
collision gas (in this case argon) is present. The precursor (or parent) ion interacts with this 
gas and the kinetic energy of the ion is transformed into internal energy which leads to the 
fragmentation of the parent into daughter ions. These daughters then pass into the second 
mass spectrometer (MS2) where they and further fragments are separated and detected. In 
short, MS1 can be considered as an ion source for MS2, as shown in figure 3.3.  
 
Figure 0.1 Diagram of the tandem mass spectrometer 
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If this filial relationship is observed in the spectrum of a pure sample of A and also from a 
mixture containing A then we can be confident that A is present in the mixture.  
3.5.3 Mode of LC-MS/MS used for EDC and PPCP analyses 
Liquid chromatography – electrospray interface - tandem mass spectrometry (LC-
ESI-MS/MS) was used for the analysis of selected pharmaceutical and endocrine disrupting 
chemicals in water and sediment samples. This method employs a solvent mobile phase for 
the separation of compounds and is the preferred method for trace analysis of compounds 
that are thermolabile and have high polarities. The LC-ESI-MS/MS method used in this 
work was developed from work by Zhang and Zhou (2007). 
The LC separation was carried out on a Waters 2695 HPLC separations module (Milford, 
MA, USA) equipped with a Waters symmetry C18 column (4.6 x 75 mm, particle size 3.5 
µm). Three eluents were used: Eluent A consisted of 0.1 % formic acid in pure water, 
eluent B was acetonitrile only and eluent C was MeOH. The gradient elution was operated 
with 10 % of eluent B, followed by a 25 minute gradient to 80 % of eluent B and a 3 
minute gradient to 100 % of eluent B. It was then changed to 100 % of eluent C within 8 
minutes and held there for 10 minutes. The system was re-equilibrated for 10 minutes 
between runs. The injection volume was 10 µL. 
The tandem MS analyses were carried out on a Micromass Quattro triple-quadrupole mass 
spectrometer equipped with a Z-spray electrospray interface. The analyses were done in PI 
mode for the other compounds. The temperatures of the electrospray source block and 
desolvation were 100 and 300 
o
C, respectively. The capillary and cone voltages were 3.0 
kV and 30 V, respectively. Nitrogen as both nebulising gas and desolvation gas was set at 
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25 and 550 L/h, respectively. Following the selection of precursor ions by the first 
quadrupole mass analyser, the collision-induced dissociation was performed by argon at 3.6 
× 10
-3
 mbar. Product ions were obtained at a series of collision energies and selected 
according to the fragmentation that produced a useful abundance of product ions. The 
optimal collision energy, cone voltage and transitions chosen for the MRM experiment 
were optimised. A dwell time of 100 ms per ion pair was adopted. The mass spectrometer 
was operated in MRM mode with unit mass resolution on both mass analysers. 
Table 3.1 LC-MS/MS MRM Parameters for Pharmaceutical and EDC analyses 
 
Compound 
 
RT 
(min) 
 
Molecular 
weight 
 
Collision 
energy 
(ev) 
 
Precursor 
ion (m/z) 
 
Product 
Ion (m/z) 
 
LOD 
(ηg/L) 
 
LOQ 
(ηg/L) 
Estradiol 17.7 272.4 30 271 145 1.2 3.6 
Estrone 19.5 270.4 30 269 183 0.60 1.8 
Ethinylestradiol 19.0 296.4 30 295 145 0.40 1.2 
Propranolol 9.9 259.15 20 260 
116  
183  
 
0.0060 
 
0.019 
Sulfamethoxazole 11.2 253.05 15 254 
92  
108  
0.043 0.14 
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156  
Mebeverine 12.2 429.00 25 430 
101  
135 
0.045 0.15 
Thioridazine 14.3 370.15 25 371 
126  
98 
0.0010 0.004 
Carbamazepine 14.8 236.09 20 237 194  0.0028 0.009 
Tamoxifen 16.8 371.22 25 372 
72  
208  
0.0030 0.009 
Indomethacine 22.0 357.09 25 358 
139  
141  
0.015 0.05 
Diclofenac 22.1 295.01 30 296 214 0.016 0.058 
Meclofenamic acid 24.1 295.01 25 296 243 0.079 0.27 
 
3.5.4Mode of GC-MS/MS used for EDC analyses 
GC-MS/MS analysis was performed using a 6890N network gas chromatograph (Agilent 
Technologies, USA) interfaced with a mass spectrometer (Quattro Micro, Micromass, 
USA) with tandem quadrapole. An Agilent 30 m HP-5 capillary column with a 0.25 mm 
internal diameter and a 0.25 µm film thickness was used. The carrier gas was helium, 
which was maintained at a constant flow rate of 1.0 mL/min. The GC column temperature 
was programmed from 100 (initial equilibrium time 1 min) to 200 
o
C via a ramp of 10 
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o
C/min, 200 - 260 
o
C via a ramp of 15 
o
C/min, 260 - 300 
o
C via a ramp of 3 
o
C/min and 
maintained at 300 
o
C for 2 min, with a total run time of 30.33 minutes.  
The MS was by positive mode electron impact ionisation and was operated in full scan 
mode from m/z 50 - 600 for qualitative analysis. For quantitative analysis multiple reaction 
monitoring (MRM) mode was used. The inlet and MS transfer line temperatures were 
maintained at 280 
o
C, and the ion source temperature was 250 
o
C. Auto-sampler injection 
(1 μL) was in splitless mode. The electron impact energy used was 70 eV.  
Calibration of the GC-MS/MS equipment was carried out by analysing the gas Heptacos 
using the calibration software that is installed on the machine. Likewise, the LC-MS/MS 
was calibrated using sodium iodide.  
3.5.5 Quantification of target compounds using GC-MS/MS and LC-MS/MS 
The quantification of the analytes from the water and sediment samples was carried out by 
comparison between analyte response (peak area) and the response from a standard solution 
containing all of the targeted compounds and two internal standards [213]. A response 
factor (RF) was calculated for each compound of interest and also for the two internal 
standards. 
RF = 
injectedion Concentrat
analyte  Response
       (0-1) 
Next, a relative response factor (RRF) was calculated by dividing the RF of each compound 
by the RF of its relevant internal standard. 
RRF = 
standard  internal RF
compound RF
       (0-2) 
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By using the RRF, the amount of the targeted compound in each sample injected could be 
calculated: 
Amount of chemical (ηg) = 
 












RRF
ηg ISAmount 
 Response
  Response
IS 
compound
  (0-3) 
Using the found amount, the concentration of each analyte in the sample could be 
calculated: 
Concentration of chemical = 
 
V)or (W    sample ofAmount 
 chemical of ηgAmount 
   (0-4) 
where W is the dry weight of the sediment sample (g) and V is the volume of the water 
sample (L). 
3.6 Characterisation of the river water samples 
3.6.1 Physical properties 
A Multiline P4 Universal Meter (Semat Ltd, UK) was used to measure salinity, 
conductivity, pH, dissolved oxygen and the temperature in situ from all of the water 
samples. The meter was calibrated prior to each sampling trip by following the 
manufacturer‟s instructions. The dissolved oxygen sensor was also regularly regenerated as 
per manufacturer‟s instructions to keep it in good working condition. 
3.6.2 Determination of the river sediment water content (%) 
The river sediment was homogenised by mixing with a stainless-steel spatula. Triplicate 
wet samples of ~10 g (W1) were transferred to pre-weighed crucibles. The samples were 
then dried in an oven at 50 
o
C for 24 h until a constant weight was achieved. The crucibles 
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and their contents were then left to cool and reweighed (W2). The water content could then 
be calculated: 
Water content (%) = 100*(W1 - W2) / W1    (0-5) 
3.7 References 
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Chapter 4. Experimental comparison of common analytical techniques for the 
measurement of steroidal estrogens in environmental water samples 
4.1. Introduction 
In terms of estrogenic activity, the most important EDCs are E1, E2 and EE2 as they are far 
more potent than other compounds such as bisphenol A or alkylphenols, and can cause fish 
feminisation at approximately the ng L
-1
 level [1][2]. Due to uncertainty in their impacts on 
terrestrial and aerial organisms as a result of a lack of data, E1, E2 and EE2 are not yet 
included in the list of 146 substances with endocrine disruption classification [3], 
nevertheless, their feminisation effects in invertebrates and fish have been confirmed 
worldwide. In addition, it is widely recognised that effluent discharges from sewage 
treatment works (STW) are the main source of EDC inputs to the aquatic environment such 
as rivers and streams [4][5]. Other sources include animal agriculture, aquaculture and 
spawning fish [14]. 
In order to minimise EDC impacts on fish populations, reliable and sensitive analytical 
methods are needed to detect EDCs in the aquatic environment. The concentrations of 
EDCs are generally low in aquatic systems, up to 19.4 ng L
-1
 in surface water, although 
levels as high as 5400 ng L
-1
 have been found in some STW effluents [7]. As a result, water 
samples are usually concentrated using solid-phase extraction (SPE). A wide variety of 
analytical techniques have been developed and subsequently optimised for EDC analyses, 
among which gas chromatography (GC) coupled with mass spectrometry (MS) and tandem 
MS is the first developed and still widely used [8][9][10][11][12]. A more recent and 
increasingly popular technique has been liquid chromatography (LC) coupled with MS or 
MS-MS which does not require sample derivatisation [13][14][15][16]. As EDCs are being 
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measured at trace levels, often close to the limit of detection (LOD) of the instruments, 
there is a need to understand how the different techniques compare in terms of their 
performance. Only by knowing which technique(s) are most reliable and reproducible, can 
we appraise relative merits and focus on the optimisation of methodologies. 
This study investigates the performance of three analytical techniques including GC-
MS, GC-MS-MS and LC-MS-MS, all previously developed and validated for the analysis 
of emerging contaminants including E1, E2 and EE2 in environmental water samples 
[10][12][17]. The influence of sample matrix on analytical quality at trace levels is highly 
important and widely speculated, and is addressed. 
4.2. Experimental  
4.2.1. Chemicals and standard solution 
All solvents used (methanol, ethyl acetate, acetone, dichloromethane, hexane and 
acetonitrile) were of distilled-in-glass grade (purchased from Rathburn Chemicals Ltd., 
Walkerburn, Scotland). EDC standards including E1, E2 and EE2, together with their 
deuterated internal standards E2-d2 were purchased from Sigma, UK. In addition, other 
internal standards E1-d4, E2-d4 and EE2-d4 and were obtained from Qmx Laboratories Ltd, 
UK, all with an isotopic purity >98%. Separate stock solutions of individual standards 
(1000 mg L
-1
) were prepared in methanol, from which working standards (10 mg L
-1
) of 
individual compounds and mixtures were prepared. All standards were stored at -18 
o
C. 
Ultrapure water was supplied by a Maxima Unit from USF Elga, UK.  
4.2.2. Sampling and sample treatment 
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Water samples (in triplicate) were collected in pre-cleaned Winchester amber-glass bottles 
(2.5 L) from four sites (sites 1-4) along the River Ray, and at one control site (site 5) on the 
River Ock, Swindon, UK. Site 1 is approximately 3.5 km upstream from the effluent of 
Rodbourne STW (adjacent to Site 2). Sites 3 and 4 are 1.7 and 8.3 km downstream of the 
effluent, respectively. Sodium azide (10 mL, 2M) was added to each sample as a general 
biocide to eliminate bacteria and thus minimise biodegradation during sample storage and 
processing. Samples were refrigerated at 4ºC until filtration and extraction. Each sample 
was filtered under vacuum using pre-ashed glass fibre filters (Whatman, GF/F). The 
filtrates were subsequently spiked with 100 ng of the internal standards.  
4.2.3. SPE 
The target compounds were extracted from the filtered water samples using SPE. Oasis® 
SPE cartridges (0.2 g HLB, Waters) were conditioned with 5 mL of ethyl acetate to remove 
residual bonding agents, followed by 5 mL of methanol which was drawn through the 
cartridges under a low vacuum to ensure that the sorbents were soaked in methanol for 5 
min. Ultrapure water (3 x 5 mL) was then passed through the cartridges at a rate of 
approximately 1-2 mL min
-1
. Water samples (2 L) were then extracted at approximately 10 
mL min
-1
, as this has been shown to be optimal [11]. The SPE cartridges were subsequently 
dried under vacuum and the extracts eluted from the sorbents into 20 mL vials with 10 mL 
of methanol at a flow rate of 1 mL min
-1
. The solvent was then blown down to 100 μL 
under a gentle N2 flow, and transferred to 300 μL microvials ready for analysis. 
4.2.4. Derivatisation 
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In the case of GC analyses of EDCs, the target compounds need to be derivatised to 
produce less polar derivatives. This enhances chromatographic performance by improving 
peak shape, reduces tailing and provides a better baseline. Briefly, the extracts were 
transferred into 3 mL reaction vials and were evaporated to dryness under a gentle stream 
of nitrogen. The dry residues were then derivatised by the addition of 50 µL each of 
pyridine (dried with KOH solid) and N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA), 
which were heated in a heating block at 60–70 oC for 30 min following a previously 
optimised method [11]. The derivatives were cooled to room temperature, evaporated under 
a gentle stream of nitrogen to dryness, reconstituted in 100 µL of hexane and transferred to 
300 μL microvials ready for analysis by GC-MS and GC-MS-MS. 
4.2.5. Sample analyses 
4.2.5.1. LC-MS/MS 
The untreated extracts in methanol were analysed using a Waters 2695 HPLC separations 
module (Waters, Milford, MA, USA) fitted with a Waters Symmetry C18 column (4.6×75 
mm, particle size 3.5 μm). The mobile phase comprised of eluent A (0.1% formic acid in 
ultrapure water), solvent B (acetonitrile) and eluent C (methanol). The flow rate was 0.2 
mL min
-1
 and the elution started with 90% eluent A:10% eluent B, a 25 min gradient to 
80% of eluent B, then a 3 min gradient to 100% eluent B, followed by an 8 minute gradient 
to  100% of eluent C. This was held for 10 min and then returned back to the initial 
conditions within 4 min. The system re-equilibration time was 10 min and the sample 
injection volume was 10 μL. The MS-MS analyses were completed with a Micromass 
Quattro triple-quadrupole mass spectrometer equipped with a Z-spray electrospray 
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interface. The analyses were in negative ion mode. The parameters for the analyses were: 
electrospray source block and desolvation temperature 100 and 300ºC, respectively; 
capillary and cone voltages 3.0 kV and 30V, respectively; argon collision gas 3.6×10
-3
 
mbar; cone nitrogen gas flow and desolvation gas: 25 and 550 L h
-1
, respectively.  
Following the selection of the precursor ions, product ions were obtained at optimum 
collision energies and were selected according to the fragmentation that produced a useful 
abundance of fragment ions. The optimal collision energy, cone voltage and transitions 
chosen for the multiple reaction monitoring (MRM) experiment were optimised and 
utilized a dwell time of 100 ms. The mass spectrometer was operated in MRM mode with 
unit mass resolution on both mass analysers. The precursor and product ions monitored for 
each compound are shown in Table 4.1. 
4.2.5.2. GC-MS/MS 
During our method development, silylated EDCs (through BSTFA) are stable for up to 120 
h with the exception of TMS-EE2 which has been found to be stable for only 48 h [18]. 
Others [26] used N-methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA) as the 
derivatisation agent and obtained stable derivatives for up to 4 weeks. Consequently as a 
result of the limitations, all GC-MS and GC-MS-MS analyses were performed immediately 
and definitely within 48 h of derivatisation. To maintain the optimum performance, regular 
changes were made to the pre-column and injector liner in GC, together with regular 
cleaning of the ion source. 
The GC-MS-MS analyses were performed using a 6890N network gas chromatograph 
(Agilent Technologies, USA) interfaced with a mass spectrometer (Quattro Micro, 
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Micromass, USA) with a tandem quadrupole. An Agilent 30 m HP-5 capillary column with 
a 0.25 mm internal diameter and a 0.25 μm film thickness was used. The carrier gas was 
helium, which was maintained at a constant flow of 1.0 mL min
-1
. The GC column 
temperature was programmed from 100 
o
C (initial equilibrium time 1 min) to 200 
o
C via a 
ramp of 10 
o
C min
-1
, 200-260 
o
C via a ramp of 15 
o
C min
-1
, 260 - 300 
o
C via a ramp of 3 
o
C 
min
-1
 and was maintained at 300 
o
C for 2 min, with a total run time of 30.33 min. The MS 
was set for positive electron impact ionisation (70 eV) and was operated in MRM mode for 
quantitative analyses, using argon as the collision gas. The inlet and MS transfer line 
temperatures were both maintained at 280 oC and the ion source temperature was 250 
o
C. 
Sample injection (1 μL) was in splitless mode. The precursor and product ions for each 
compound are shown in Table 4.1. 
4.2.5.3. GC-ion trap-MS 
GC–MS analyses were performed using a gas chromatograph (Trace GC 2000, Themoquest 
CE Instruments, TX, USA) coupled with an ion trap mass spectrometer (Polaris Q, 
Themoquest CE Instruments, Texas, USA) and an autosampler (AS 2000). A ZB5 (5% 
diphenyl–95% dimethylpolysiloxane) capillary column of 30 m × 0.25 mm i.d. (0.25 m 
film thickness) was used. Helium carrier gas was maintained at a constant flow rate of 1.5 
mL min
-1
, which was found to be the optimum for the separation of target compounds. The 
GC column temperature was programmed from 100 
o
C (initial equilibrium time 1 min) to 
200 
o
C via a ramp of 10 
o
C min
-1
, 200–260 oC via a ramp of 15 oC min-1, 260–300 oC via a 
ramp of 3 
o
C min
-1
 and maintained at 300 
o
C for 2 min. The MS was adjusted for selected 
ion monitoring mode for quantitative analyses. The inlet and MS transfer line temperatures 
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were both maintained at 280 
o
C, and the ion source temperature was 250 
o
C. Sample 
injection was in splitless mode. The ions monitored are shown in Table 4.1. 
 
Table 4.1 Retention times (RT) and ions used for the analysis of E1, E2 and EE2 and their 
respective deuterated internal standards 
Compound                       LC-MS-MS              GC-MS-MS                               GC-MS 
 
RT 
Precursor 
Ion 
Product 
Ion RT 
Precursor 
Ion 
Product 
Ion RT 
Quantification 
Ion 
Confirmation 
Ion 
E1-d4 - - - - - - 14.44 346 (100%) 
257 (100%) 
285 (30%) 
E1 19.50 269 183 18.10 342 
257 
(100%)  
327 
(10%) 
14.51 342 (100%) 
257 (100%) 
218 (20%) 
E2-d4 - - - - - - 17.72 289 (100%) 
420 (100%) 
330 (35%) 
E2-d2 17.75 273 186 18.50 418 
287 
(100%) 
233 
(75%) 
- - - 
E2 17.70 271 145 18.50 416 
285 
(100%) 
243 
(28%) 
18.08 285 (100%) 
416 (100%) 
326 (40%) 
EE2-d4 - - - - - - 19.29 289 (100%) 
430 (100%) 
289 (30%) 
EE2 19.05 295 145 19.70 425 
193 
(100%)  
231 
(70%) 
19.42 285 (100%) 
425 (100%) 
232 (30%) 
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4.3. Results and discussion 
4.3.1. Validation of the analytical methods 
Chromatograms for the three steroidal estrogens and their associated internal standards are 
shown in Fig. 4.1. In GC-MS-MS or LC-MS-MS operation, E2-d2 was the only deuterated 
internal standard found to give a satisfactory response with these instruments. A visual 
comparison of the three chromatograms suggests little difference in the quality of the 
separation of the standards. Analysis of deuterated internal standards by LC-MS-MS 
proved, however, to be more difficult than with the GC techniques owing to higher 
background noise (even with E2-d2). All three analytical techniques relied upon SPE as the 
pre-concentration step, which has been assessed extensively for EDC recovery [10][12]. 
Each method was then thoroughly validated for the linear range of calibration curve, 
sensitivity, specificity, blanks, precision and bias (through the use of recovery experiments 
due to lack of certified reference materials). The linear ranges of calibration curve for the 
GC-MS and GC-MS-MS have previously been determined, from 1 to 500 ng L
-1
 [10][12]. 
The linear range for the LC-tandem MS was between 15-750 ng L
-1
. The limit of detection 
(LOD), defined as the concentration that corresponds to three times the standard deviation 
of blanks, was measured by integrating blank peak area for each analyte in 10 independent 
performances with ultrapure water as the blank. As shown in Table 2, the GC-MS-MS 
method offers improved performance over the two alternatives with regard to LOD. The 
LOD for the GC-MS technique is relatively poor among the three techniques. The analysis 
of procedural blanks (blanks being treated as samples) did not detect any of the three 
compounds in our regular sampling trips, confirming a good quality procedure. 
Furthermore, extensive recovery experiments were performed regularly by the spiking of 
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the three estrogens at different levels (1 ng L
-1
, 20 ng L
-1
, 50 ng L
-1
, 100 ng L
-1
, 200 ng L
-1
) 
in different waters (e.g. river water, seawater, groundwater, wastewater), with satisfactory 
recoveries from 72-119% [10][12]. In addition, an inter-calibration exercise was undertaken 
recently with three other laboratories in the UK, among which a good agreement was 
achieved.   
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Figure 4.1 Chromatograms of a 10-ng mL
−1
 standard mix (i) and an effluent (site 2) sample 
(ii) as analysed by (a) GC–ion trap-MS, (b) GC–MS–MS and (c) LC–ESI–MS–MS. Peaks 
are (1) E1-d4, (2) E1, (3) E2-d4, (4) E2, (5) EE2-d4, (6) EE2 and (7) E2-d2.  
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Compound GC-MS GC-MS-MS LC-MS-MS 
E1 0.7 0.3 0.6 
E2 1.4 0.3 1.2 
EE2 0.8 0.3 0.4 
Table 4.2 Limits of detection (ng L
-1
) for three steroidal estrogens by each method 
4.3.2. Application of the analytical methods 
Once validated, the techniques were applied to the EDC analysis of environmental sample 
extracts. Overall, the LC-MS-MS was observed to be most heavily affected by matrix 
interferences in terms of elevated background noise and reduced peak area for the target 
compounds. Similar matrix interference effect in LC-tandem MS has been reported by 
Beck et al. [10], who observed a signal suppression of between 80-85% for the three 
compounds. As a result, the signal-to-noise ratio was reduced such that peaks were less 
clear than in either of the GC techniques. Surprisingly, a significant interference for the 
analysis of EE2 was noted for GC-MS-MS of some effluent sample extracts. For both 
standards and sample extracts, the GC-MS technique appears to offer the best baseline of 
the three techniques, but it lacks the robustness of the tandem MS techniques, where 
fragment ions are used to confirm the identity of the analytes. 
As the LOD for the GC-MS technique is relatively poor, its signal quality rapidly 
declines with a reduction in concentration of the analytes, and as can be seen (Fig. 4.2), 
several of the environmental samples analysed were below LOD for this instrument. 
However, each of three techniques is operating at or near their detection limits for many of 
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the samples for at least one of the estrogens due to matrix interferences. The three 
techniques used here, however, reflect LODs reported by other laboratories using similar 
extraction and analytical techniques, which range from 0.1-1 ng L
-1
 [15,16,27] for each 
compound. 
As is shown in Fig. 4.2 there is a very good agreement between the three techniques, 
particularly for E1 (0.1-0.2 ng L
-1
 difference between techinques, RSD = 28%) and E2 
(<0.1 to 0.2 ng L
-1
, RSD = 4%). However, it is evident that the LC-MS-MS measurements 
of EE2 are significantly higher than measurements by GC techniques, particularly in areas 
where matrix interferences are likely to be high (e.g. sewage effluents), as a result there is a 
larger variabililty in measured concentrations between the three techniques for EE2 (0.1-1 
ng L
-1
, RSD = 45%). The precision for each technique which is comparable across the 
techniques, is the lowest for the GC-MS-MS technique.In addition, all three techniques 
identify the STW effluent (site 2) as the location at which concentrations of the three 
estrogens are the highest. This shows that all three techniques are consistent in their 
identification of pollution hotspots. The results are in agreement with other studies 
[4][5][10] which identify sewage effluent as the primary source of steroidal estrogens in 
river waters. 
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Technique
E1
E2
EE2
  <LOD 
Compound GC-MS GC-MS-MS LC-MS-MS 
E1 0.7 0.3 0.6 
E2 1.4 0.3 1.2 
EE2 0.8 0.3 0.4 
Table 4.2 Limits of detection (ng L
-1
) for three steroidal estrogens by each method 
Figure 4.2 Analyses of samples from 5 sampling locations for estrone (E1), estradiol (E2) 
and ethinylestrodiol (EE2) by GC-MS-MS, GC-MS and LC-MS-MS 
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4.3.3 Comparisons with other analytical techniques 
To ensure the data produced by the participating laboratories as part of the EDCAT project, 
an intercalibration programme was established with sought to compare the results produced 
by each laboratory for spiked samples with unknown concentrations of estrogenic 
compounds, together with an unknown effluent sample.  
 
4.3.3.1 Method of inter-comparison 
The inter-comparison was co-ordinated and led by Cefas. Freshwater from a borehole at the 
Cefas former Burnham Laboratory site, was „spiked‟ with the three oestrogens, E1, E2 and 
EE2 at two different concentrations. Five samples of each concentration along with an 
unspiked sample and a wastewater effluent were sent to the following laboratories: Centre 
for Environment Fisheries and Aquaculture Science (Cefas), Sussex University (Sussex), 
Plymouth Marine Laboratory (PML) and Centre for Ecology and Hydrology Wallingford 
(CEH).   
 
Each laboratory employed a range of sample processing and analytical techniques. PML 
employed liquid-liquid extraction (in DCM) with rotary evaporation, with subsequent 
analysis by GC-MS. CEH employed an SPE-LC-MS technique. CEFAS employed an SPE-
disk-GC-ion trap-MS technique. At Sussex, LC-MS/MS was used for the results reported to 
Cefas and were confirmed using GC-MS/MS. 
 
4.3.3.2 Results of inter-comparison 
After submitting data to Cefas, it was revealed that the two spiked sets of samples were 
spiked at 20ng/L and 1ng/L. As is shown in Table 4.3, there was poor agreement between 
laboratories for the effluent samples. LC-MS/MS analysis appears to have over-estimated 
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concentrations of E2 and EE2 compared to analyses by GC-MS(/MS) based techniques 
employed both at Sussex and elsewhere. Results for E1 however are more encouraging, 
with good agreement between the LC-MS/MS technique and other laboratories. Table 4.4 
shows the results from each laboratory for the analyses of the two sets of samples spiked 
with standards.  
 
 
 
 
 
 
 
 
 
Table 4.3 Results for the effluent sample (ng l
-1
) 
The results shown in tables 4.3 4.4 are encouraging. At the 20 ng l
-1 
level there is good 
agreement between the LC-MS/MS technique described in chapter 3 (and compared 
internally in previous sections of this chapter) compare favourably with the techniques 
employed by other laboratories, with acceptable levels of error for E2 and EE2 
measurements, although E1 is slightly over-estimated. There is a significant over-
estimation of concentration measured in samples spiked at 1 ng l
-1
, more environmentally-
Participant 
Analytical 
instrument 
Sample E1 E2 EE2 
Sussex LC-MS/MS Effluent 50 43 21 
 GC-
MS/MS 
Effluent 26.7 <0.3 <0.3 
 GC-ion 
trapMS 
Effluent 25.6 <1.4 1.5 
PML  Effluent 34 11  
Cefas  Effluent 47 8.4 0.6 
Cefas  Effluent 
Preserved 
53 19 2.3 
  Mean. 45.9 20.3 8 
  SD  8.5 15.4 11.0 
  CV(%) 18.4 76.1 141.7 
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relevant concentrations by the LC-MS/MS technique, possibly as a result of matrix 
interference. Again, this issue was most severe for E1 analyses, but it should be noted that 
all laboratories with the exception of PML (which under-estimated) over-estimated 
concentrations at this level, suggesting the possibility that there may have been some error 
in the spiking at this level, since there is good agreement in this over-estimation. 
  Sample A Sample B 
 Participant Compound mean 95% 
confidence 
interval 
Z mean 95% 
confidence 
interval 
Z 
        
CEH E1 
E2 
EE2 
21.0 
22.5 
19.5 
18.0, 24.0 
20.0, 25.1* 
16.2, 22.8 
0.73 
2.14 
-0.34 
3.52 
4.96 
1.04 
2.98, 4.06* 
4.11, 5.81* 
0.79, 1.29 
10.19 
10.18 
0.34 
Sussex E1 
E2 
EE2 
22.5 
19.9 
19.4 
19.5, 25.5 
17.3, 22.4 
16.1, 22.7 
1.84 
-0.10 
-0.39 
2.52 
1.34 
1.78 
1.98, 3.06* 
0.49, 2.19 
1.53, 2.03* 
6.15 
0.87 
6.69 
PML E1 
E2 
EE2 
16.9 
18.3 
18.4 
13.0, 20.8 
14.2, 22.4 
14.2, 22.7 
-1.75 
-1.12 
-0.80 
0.63 
0.90 
1.03 
-0.06, 1.33 
-0.19, 1.99 
0.71, 1.36 
-1.15 
-0.20 
0.22 
Cefas E1 
E2 
EE2 
20.0 
17.3 
16.3 
16.4, 24.1 
13.3, 21.4 
12.1, 20.6 
0.13 
-1.76 
-1.87 
2.20 
2.70 
1.70 
1.35, 3.05* 
1.36, 4.04* 
1.30, 2.10* 
3.07 
2.76 
3.80 
Table 4.4 Results compared against 20 ng l
-1 
spiked samples (sample A) and against 1.0 ng 
l
-1 
spiked samples
 
(* denotes statistically significantly different at the 5% level) 
4.4 Conclusions 
Three popular techniques for the analysis of steroidal estrogens in the aquatic environment 
have been compared. It has been observed that overall, the three techniques appear 
100 
 
comparable, but that tandem-mass spectrometric techniques are able to detect at lower 
concentration levels of the three steroidal estrogens of interest. In particular, the GC-MS 
technique fails to detect the pollutants at the lower-end of environmentally relevant 
concentrations. However, the LC-MS-MS technique is more susceptible to matrix 
interferences for the analysis of samples resulting in a reduction of the signal-to-noise ratio 
and a subsequent reduction in reliability and stability. With the GC-MS-MS offering 
increased selectivity, the lowest LOD, and with a good a signal-to-noise ratio for all 
compounds in all samples, it is regarded as the preferred analytical method for the reliable 
identification and analysis of estrogens in environmental water samples. However, it does 
require derivatisation of samples prior to injection, which can be time consuming and 
therefore a disadvantage for sample throughput. Additionally, LC-MS-MS affords the 
sequential analysis of both estrogenic and pharmaceutical compounds, without requiring 
any additional treatment of samples, allowing for the simultaneous detection of both classes 
of pollutant.  
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Chapter 5. Improvement of sample treatment techniques to reduce uncertainty of 
analyses of EDCs and Pharmaceuticals in environmental samples 
5.1 Introduction 
Measurements of contaminant concentration in the environment inevitably have 
uncertainty. At each stage of an analytical procedure, there are potential sources of 
uncertainty, as shown in table 5.1.  
Table 5.1 Sources of uncertainty in the analysis of contaminants in environmental 
Steps of analytical procedure Sources of Uncertainty 
Sampling Representativeness  
Sample contamination 
Sample storage Analyte transformation 
Loss of analyte 
Treatment Analyte transformation 
Loss of analyte  
Extract purification 
Determination Separation 
Identification 
Calibration 
Detection 
 
In Chapter 4, it was discussed that in order to fully understand the risk posed by emerging 
pollutants, it is necessary to have precise and accurate analytical procedures. To improve 
the quality of analytical data, researchers seek to reduce sources of uncertainty optimizing 
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the analytical procedures used. These efforts often focus on the development of highly 
optimised techniques for final separation and detection, such as chromatography and mass 
spectrometric analysis, but little attention is paid to the other factors that may represent 
sources of uncertainty, including, but not limited to, sample preparation and storage. This 
chapter seeks to evaluate some of these sources of uncertainty experimentally and suggest 
optimised strategies to reduce them.  
Although it is acknowledged that samples should be prepared and analysed immediately 
after collection, this is not always practical. It is inevitable that samples are stored prior to 
analysis, possibly for significant periods of time. Internal standards, due to their similar 
chemistry are widely assumed to degrade at a rate identical to that of their analyte 
counterparts, but it is nevertheless preferable to minimise any degradation to reduce any 
uncertainty that may arise due to any variability in this. There is little understanding of how 
the the possible loss of analyte compounds during this storage affects the quality of data 
produced by subsequent analysis, which this chapter seeks to address. 
It is common for researchers to employ a preservation technique to prevent degradation of 
analyte compounds. Photo-degradation has been shown to rapidly degrade both E1 and E2 -  
Zhang et al. (2007) [1] found 94% degradation of both compounds within 1h when exposed 
to UV radiation. However, due to the widespread storage of samples in dark refrigeration, it 
is unlikely that photo-degradation nor thermal degradation are a significant cause for 
concern in most analytical applications.  It is, therefore, assumed that the most significant 
process of degradation is as a result of biotic processes, and as such, many researchers use 
preservative agents that seek to minimise biotic growth in water samples. However, peer-
reviewed research to evaluate the efficacy of these different preservative agents is scarce, 
104 
 
and as such, there is wide variation in the use of different preservatives, with little 
understanding of the implications this may have for cross-comparison of results, nor for the 
validity of data in some studies. Fuhrman et al. [5] examined the stability of estrogens and 
estrogen metabolites in human blood and urine samples using acidification treatment, and 
found no significant benefit of this treatment. However, the concentrations of estrogenic 
compounds in these samples is typically significantly higher ~2 orders of magnitude in 
their study. The US EPA [6] conducted a review of their storage and preservation practice 
of environmental samples for analysis of steroidal estrogens and pharmaceutically-active 
compounds and concluded that: glass or PTFE amber bottles should be used; acidification 
should be used to dechlorinate samples; and that samples should be stored in dark 
refrigeration; samples should be extracted and analysed within 7 days.  
In this chapter, the significance of sample storage conditions are investigated, and 
preservative techniques which offer optimal recovery and allow storage of samples for the 
longest period of time are identified.  
5.2 Experimental 
5.2.1 Sample collection and treatment 
Water samples were collected from the river Ray, in Wiltshire, UK. It is a tributary of the 
river Thames and is a conduit for effluent from Rodbourne STW, a large, modern treatment 
works in Swindon. Samples were collected into ~50 L stainless steel barrels and were 
subsequently brought back to the laboratory where they were stored in dark refrigeration 
until further processing. The actual volume of water collected was found by weighing each 
barrel before and after sampling.  
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Sub-samples (3x 500mL) were taken from each barrel, prepared for analysis, and 
subsequently analysed by LC-MS-MS for estrogenic and pharmaceutical compounds within 
24 hours, to allow an understanding of background concentrations of these compounds, 
used in subsequent calculations of concentration. Subsequent to this, each barrel was spiked 
with 500ngL
-1
 of a standard mixture of both pharmaceutical and estrogenic compounds, 
prepared as detailed in chapter 3; together with a preservative agent as shown in table 5.2. 
Although it is recognised that this level of spiking exceeds environmentally relevant 
concentrations, it was chosen to minimise mass-spectrometric analytical uncertainties and 
to avoid the possibility of non-detection. The selection of preservatives was based upon the 
assessment of (1) published analytical procedures used for the determination of estrogens, 
(2) pharmaceuticals and (3) other organic contaminants. However, it was found that many 
articles did not report the volume of preservative agent used. As a result of this, the volume 
of preservative was decided upon based upon (1) existing published techniques (2) 
understanding of their microbial-growth inhibition and (3) understanding of their potential 
to interfere with chromatographic separation. pH adjustment was achieved 
stoichiometrically using 1M sulphuric acid and calcium carbonate (Sigma, UK), and 
confirmed with an Accumet 925 laboratory pH meter (Fisher, UK). Sub-samples (3x 
500mL) were taken daily for 25 days and analysed by LC-MS-MS, as described in chapter 
3, for both estrogenic and pharmaceutical compounds. 
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Table 5.2 Preservative agents examined in this study 
 
 
 
 
 
 
 
 
5.3. Results and discussion 
5.3.1. Initial Concentrations of Estrogens and Pharmaceutical Compounds  
By mass, it was found that the barrels contained slightly more than 50L of effluent sample 
(53.2L-54.1L) and so the addition of standard mixtures was adjusted to account for this. 
Initial background concentrations were recorded for each barrel and for each compound and 
deducted from further results accordingly. These initial concentrations ranged from 
<L.O.D. for EE2 to 144ngL
-1 
for carbemazepine and there was little (<5%) variation 
between barrels, suggesting that each barrel contained of similar samples of water. After 
the addition of the standard mixture and preservative agents, sub-samples were immediately 
prepared and analysed (day 0), to confirm that all samples contained 500ngL
-1
 of analyte 
Sample ID Preservative agent  
1 Sodium Azide  
2 Formaldehyde  
3 Dichloromethane  
4 pH adjustment – pH 4  
5 pH adjustment – pH 2  
6 pH adjustment – pH 9  
7 Control (no preservative)  
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compounds and to allow for the correction of analytical losses and errors that may result 
from interference caused by the preservative agent,  in subsequent analyses  
5.3.2. Degradation of Estrogens and Pharmaceutical Compounds over time 
Figure 5.1 shows the aggregated mean of all pharmaceutical compounds tested in each 
barrel over the 25 day test period. There is a reduction in detectable mean concentration of 
between (2-6.4%) which may be due as a result of the time it takes for homogenisation and 
stabilisation of the preservatives to occur. Overall, sodium azide represents the most 
effective degradation-inhibiting agent for the pharmaceuticals tested, with a mean loss of 
6.2% over the 25-day period, and 4.1% after the 24 days from day 2 (i.e. after stabilisation). 
The data suggests that the control sample with no preservative agent gave similar results to 
sodium azide for the first 7 days, after which there was a rapid loss of pharmaceutical 
compounds (mean loss after 24 days 12.6%). The barrel which had been adjusted to pH 2 
caused the most significant loss in initial detectable pharmaceutical compounds (7.1%) but 
was more stable after this initial loss than other preservation techniques, with a loss of 5.1% 
over the 24 days from day 2.   
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Figure 5.1 Concentrations of pharmaceutical compounds as detected in sub-samples of 
each barrel up to 25 days after spiking  (error bars are standard deviation,  n=3) 
However, for estrogenic substances it is less clear which technique gives optimal results. 
As is shown in figure 5.2, sodium azide, a commonly used preservative for studies of 
estrogens in environmental samples,  is not effective in stabilizing E1, E2 or EE2 for 
significant periods of time.  There is a rapid decline in concentrations of E2 within 7 days, 
associated with a period where production of E1 (as a degradation product of E2) almost 
equals degradation of E1. This is not unexpected, since although the degradation pathways 
of E1 and E2 are not fully understood, it has been reported [1] that E2 is more rapidly 
degraded, and has been shown to produce E1 [1] as part of its biodegradation pathway.  
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Figure 5.2 Concentrations of E1, E2 and EE2 as detected in sub-samples effluent treated 
with sodium azide up to 25 days after spiking (error bars are standard deviation,  n=3) 
 
Figure 5.3 shows the combined mean of E1, E2 and EE2 in each barrel, as detected by LC-
MS/MS over the 25 days. As shown, adjustment of pH by sulphuric acid to pH 4 is has 
been found to offer the greatest stability over the 25 day period with a 7.5% loss after 25 
days, compared with a 12.2% loss after 25 days in the control. However, for shorter storage 
times (< 10 days) sodium azide may be more suitable, since mean estrogen concentrations 
of effluent treated with it were found to have a percentage loss after 9 days of 5.1%. This is 
further supported if Estrogenic activity-equivalence (EEQ) is considered. EEQ considers 
the individual potency of each estrogenic substance, affording a better understanding of the 
actual estrogenic potential of effluent and comparison with biological analysis techniques. 
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Figure 5.3 Mean concentrations of estrogenic substances as analysed in sub-samples 
effluent treated with different preservative techniques up to 25 days after spiking (error bars 
are standard deviation,  n=3) 
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Figure 5.4 EEQ as calculated from analyses of sub-samples effluent treated with different 
preservative techniques up to 25 days after spiking (error bars are standard deviation,  n=3) 
 
Figure 5.4 shows Estrogenic activity-equivalence (EEQ) of each barrel over the 25-day 
period. Since EEQ allows for a better understanding of the actual estrogenic potential of 
effluent, it is therefore, perhaps more useful than a simple combined mean of E1, E2 and 
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EE2 concentrations, as it considers the individual potency of each estrogenic substance and 
allows better comparison with biological analysis techniques. It is directly linked to 
concentration:    EEQ=CE2+1/3CE1+10CEE2 
Where CE2,CE1 and CEE2 are the concentrations of E2, E1 and EE2 respectively.  
As can be seen, there is a clear reduction in the estrogenic potential of samples over time 
regardless of which preservative is used. This may have significant implications for the risk 
assessment posed by estrogenic substances in aquatic environments, where analytical data 
may under-estimate the estrogenic activity of samples. It is therefore suggested that 
irrespective of preservation technique used, samples should be prepared for analysis as 
soon as possible after collection, so as to reduce the potential for estrogenic compounds to 
degrade.   
5.3.3. Application to environmental samples 
Each preservation technique was subsequently used for environmental samples collected 
from the influent and effluent of Scaynes Hill STW in West Sussex, UK, 10m downstream 
and 10m upstream of its effluent in the river Ouse, Sussex. 50L samples were collected (as 
in chapter 3) at each site and brought back to the laboratory with 1-hour for immediate 
treatment with preservative and 10μg/L internal standards of both pharmaceutical and 
estrogenic compounds were added. Triplicate sub-samples (3x2L) were subsequently taken 
and prepared for analysis. Samples were then stored in dark refrigeration and sub-samples 
taken every 24 hours for analysis, as previously. Figure 5.5 shows estrogenic equivalence in 
influent samples as detected by LC-MS/MS over 25 days.  
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Figure 5.5 EEQ as calculated from analyses of sub-samples of influent from Scaynes Hill 
STW up to 25 days after sampling (error bars are standard deviation,  n=3) 
As can been seen, initial EEQ was found to be in the 19.7-21.3 range with relatively good 
agreement between samples treated with the different preservation techniques, although 
samples containing copper and sodium azide appear to have slightly higher concentrations 
initially, which may be due to interference caused to chromatography separation or mass 
spectrometric analyses, or due to slight natural variations between the samples. This 
relatively high EEQ is likely due to this being untreated raw sewage. However, in samples 
treated with sodium azide there is a rapid decline in detected estrogens, and albeit after a 
brief increase in EEQ after 3-4 days, likely due to the production of E1 as a breakdown 
product of E2, detected estrogens after 5 days are amongst the lowest of all preservation 
techniques. It is not clear which preservation techniques provides optimum storage 
conditions for periods over longer periods of time, but it is clear that regardless of the 
preservation technique used, there is significant reduction in the estrogenic activity detected 
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in influent samples due to the high content of microbial organisms suspected to be present 
in STW influent.  
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Figure 5.6 EEQ as calculated from analyses of sub-samples of effluent from Scaynes Hill 
STW up to 25 days after sampling (error bars are standard deviation,  n=3) 
Figure 5.6 shows EEQ in effluent from the Scaynes Hill STW. The reduction in detected 
estrogenic activity is less marked than in influent, possibly as a result of the reduced 
number of microbial organisms likely to be present in STW effluent compared to influent. 
However, with a mean reduction of 7.2% over the 25 days, it is not insignificant.  
Concentrations of estrogens were below the limit of detection in all samples. However, as is 
shown in figure 5.7 estrogenic compounds were detected in samples 10m downstream of 
effluent. EE2 was no detected in any downstream samples, and as such, the EEQ values 
include only E1 and E2. However, with time, E2 was degraded to a level at which it was no 
longer detectable. This serves to highlight the importance of sample storage as a source of 
uncertainty. Since a laboratory which had stored samples for >10 days using one of the 
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common preservation techniques, before processing, might incorrectly report no estrogenic 
activity in those samples. In this regard, pH adjustment to pH4 appears to offer the 
optimum conditions for sample storage, since it was possible to detect E2 up to 15 days 
after sample collection, with the least (6.3%) loss of all preservation techniques.  
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Figure 5.7 EEQ as calculated from analyses of sub-samples of river water collected  from 
the River Ouse, 10m downstream of the Scaynes Hill STW effluent, up to 16 days after 
sampling (error bars are standard deviation,  n=3) 
5.4. Conclusions 
The results of this research suggest that further research is needed to better understand the 
degradation of samples in storage, and the efficacy of preservation techniques. It suggests 
that no commonly employed preservation technique prevents degradation of analyte 
compounds completely. These findings concur with the scarce number of pre-existing 
publications; Noppe et al. [7] found that E1, E2 and EE2 rapidly degraded in storage (up to 
90% within 7 days) despite employing a published procedure using acidification. Baronti et 
al. [8] contrastingly, suggest that the use of acidification or formaldehyde may accelerate 
115 
 
the oxidation of E2 to E1, with their analyses detecting concentrations of E1 significantly 
higher than that they spiked samples with and background levels.   Benjits et al. [9] 
however, found that samples extracted by SPE within 2 days of sample collection could be 
stored for up to 7 days before any loss of analyte was detected.  
It is apparent that the mechanisms for the degradation of estrogens and pharmaceutical 
compounds in samples is unclear – there are many potential pathways – biotic, chemical or 
adsorptive, and further research is required to determine conclusively which of these 
mechanisms is the primary cause of sample degradation. However, since the degradation 
does not appear to be first order, it is possible that atypical processes are occurring. Due to 
the estrogens‟ high affinity for organic matter [2] and relatively low water solubility [3], 
together with EPISUITE behaviour predictions, suggest it is possible that estrogens may 
have accumulated on organic matter or sediment, or even adsorbed to debris on the barrel 
surface, which due to its density may have sunk to the bottom of the barrel or been removed 
during filtration. Quantitative extraction and analysis of estrogens in filtration retentate will 
afford a greater understanding of losses via this mechanism, although this may not be 
possible until more robust and sensitive extraction analytical techniques evolve.  
 This lack of understanding has significant consequences for the analyses of estrogenic and 
pharmaceutical compounds, as well as in the analysis of wider emerging pollutants. These 
consequences are exacerbated where researchers do not give full details of the preservation 
techniques employed in their research, nor the time that samples are stored prior to 
processing. Where this information is lacking, there will inevitably be uncertainties when 
trying to compare data between researchers where analyte compounds degrade whilst 
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samples are in storage. Furthermore, this makes prioritization of risk more challenging 
where there is inconsistency in data and the potential for under-reporting of concentrations. 
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Chapter 6. The Occurrence of Steroidal Estrogens and Pharmaceutical Compounds in 
Water, Sediment and Wastewater and the implications of Modern STW Treatment 
Techniques 
6.1. Introduction 
As discussed in chapter 2, endocrine disrupting chemicals (EDCs) are classed as „emerging 
pollutants‟, which are those chemicals that have recently been shown to occur in water 
resources and are identified as being a potential environmental or health risk, and yet 
adequate data do not exist to determine their risk. The majority of EDCs and are man-made, 
organic chemicals, introduced to the environment by anthropogenic inputs, e.g. 17α-
ethinylestradiol (EE2) is the main component of the oral contraceptive pill. In addition, 
EDCs can be naturally-occurring in the environment, e.g. the female hormones estrone (E1) 
and 17β-estradiol (E2) are both excreted by females and are hence ubiquitous in the aquatic 
environment. Such compounds may not be removed by sewage treatment works (STW) and 
may even be reactivated through deconjugation during these processes [8][9][10]  
EDCs are of global concern and are broadly defined as chemicals that may interfere 
with the function of the endocrine systems in wildlife and humans. Endocrine disruption 
has been shown to reduce fish fertility, to be linked to human cancers and may also affect 
human fertility [9][10] A wide range of compounds has been found to possess, or are 
suspected of possessing, endocrine disrupting properties. Many EDCs are classified as 
priority substances in the EU Water Framework Directive (2000/60/EC). Due to their 
potency, the steroidal estrogens, such as the natural E1 and E2, and the synthetic EE2 are of 
greatest concern and have been found to exhibit feminising affects on fish at very low 
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concentrations (<1 ng/L) [5][6]. Steroidal estrogens have been found to persist through 
many sewage treatment processes [9][10][11][12] , and it is widely recognised that effluent 
discharges STW are the main source of EDC inputs to the aquatic environment, such as 
rivers and streams [13][14][15][16]. Although the concentrations of steroidal EDCs are 
generally low in aquatic systems, concentrations of up to 19.4 ng/L have been detected in 
surface waters, and levels as high as 5400 ng/L have been found in some STW effluents 
[11].  
Due to increasing concerns for the implications for fish populations and human health 
and the identification of sewage effluents as the major point source, a research focus in 
recent years has been on the identification of suitable technologies which satisfactorily 
remove emerging pollutants, from wastewater. Granular activated carbon (GAC), albeit 
expensive, has been shown to be applicable in the removal of other organic pollutants, and 
has been proposed as a potential technique to aid in the effective removal of emerging 
pollutants, particularly EDCs in wastewater treatment [16]. In this chapter, a study to assess 
the removal efficacy for steroidal estrogens by a recently-commissioned, post-tertiary GAC 
plant, through the analysis of pre-and post- GAC installation effluent samples over two 24-
h periods is described. The concentrations of the selected steroidal compounds have also 
been analysed at various locations upstream and downstream of the effluent in the receiving 
river, to evaluate the impact of GAC on the quality on the receiving water and to better 
understand the long-term temporal and spatial variability of these compounds. 
6.2. Experimental 
6.2.1. Chemicals and standard solutions 
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All of the solvents used, including methanol and acetonitrile, were purchased from 
Rathburns, UK, and were of distilled-in-glass grade. Authentic chemical standards 
including E1, E2 and EE2, were purchased from Sigma, UK. Deuterated internal standards, 
E2-d2, E2-d4, EE2-d4 and E1-d4 were also purchased from Sigma, UK. All standards were 
prepared in methanol and were stored at -18
o
C. Ultrapure water was supplied by a Maxima 
Unit from USF Elga, UK. 
6.2.2. Sampling and sample treatment 
Effluent samples were collected from the Rodbourne STW in Swindon, Wiltshire, UK, 
which serves a population of approximately 155000 and its effluent is received by the river 
Ray, a tributary of the river Thames. The treatment processes and technologies of the 
studied STW are shown in Fig. 6.1.  
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(b) 
 
Figure 6.1 A flow diagram of the (a) STW and (b) GAC Plant under investigation in this 
study 
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Table 6.1 Effluent sampling times over the two 24-h periods 
 Effluent samples were collected into pre-cleaned 50 L stainless steel barrels, by an 
automated pumping system set to collect samples at 4-h intervals. The sampling schedule is 
shown in Table 6.1. Triplicate spot samples were also collected 4-times per year (spring, 
summer, autumn and winter) over 3 years from 2006-2008 from four sites on the River Ray  
and one site on the River Ock (in Oxfordshire) acting as a reference. Information about 
these sites is shown in table 6.2. Due to site restrictions from the water company concerned 
on health and safety grounds, influent samples were not allowed to be taken. It is therefore 
the limitation of this work that a direct comparison between influent and effluent samples 
could not be made. Spot samples (2.5 L) taken by a semi-automatic sampler that opened at 
a depth of ∼0.5 m were collected in pre-cleaned amber bottles to which 10 mL of 2 M 
sodium azide (Fisher, UK) was added as a broad-spectrum biocide. The bottles were 
 Pre-GAC (21/22 February 2008) Post-GAC (22-23 September 2008) 
Barrel No. Start time End time Start time End time 
barrel 1 10:00 10:28 13:35 14:00 
barrel 2 14:15 15:15 17:35 18:05 
barrel 3 18:00 18:30 21:35 22:05 
barrel 4 22:00 22:30 Pump failure Pump failure 
barrel 5 02:00 02:30 05:35 06:05 
barrel 6 06:00 06.:30 09:35 10:15 
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returned to the laboratory where they were stored at 4 °C. In addition, POCIS samplers 
were deployed at the same sites 1 month before water sampling for around 28 d, and on 
retrieval, water samples were taken for chemical analyses and additionally vitro assay 
analyses by CEFAS. 
River Site Grid Ref. Description Distance from Rodbourne STW 
discharge (km) 
Ray #1 SU138833 Westleaze 3.5 Upstream 
Ray #2 SU127859 Rodbourne STW 
effluent 
∼0.1 Downstream 
Ray #3 SU121872 Elborough bridge 2.0 Downstream 
Ray #4 SU119925 Seven bridges bridge 10 Downstream 
Ock #5 SU382943 Charney bassett Control site 
Table 6.2. Site numbers, location and description used in EDCAT sampling. 
 
The river Cole had initially been the preferred control river due to its close proximity to 
the Ray, but due to it being highly-engineered and the resulting inability to support fish 
populations, it was decided to be unsuitable. Sodium azide (5mL/L, 2M) was added to all 
water samples as a general biocide to eliminate bacteria and thus minimise biodegradation 
during sample storage and processing, although sample processing on return to the 
laboratory was performed as soon as practicable to further minimise degradation.  
Water samples were refrigerated at 4ºC until filtration and extraction. Samples were 
processed following previously published methods, details of which can be found in 
chapter 3. Briefly, samples were filtered under vacuum using pre-ashed glass fibre filters 
(Whatman, GF/F; 0.7 μm pore size). Filtered samples (2 L) in triplicate were spiked with 
internal standards (100 ng). Sediment samples were frozen and freeze-dried, and 
subsequently underwent extraction by MAE, the extracts of which were subsequently 
reduced in volume by rotary evaporation and under a gentle N2 stream, diluted into 500mL 
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of ultrapure water and treated as water samples. Further details of these procedures are also 
available in chapter 3. 
 
 
Figure 6.2  A site map to show sampling locations on the River Ray indicating distances 
from the Rodbourne STW effluent (u/s: upstream, d/s: downstream). Site 5 as a reference in 
the river Ock is not shown. 
6.2.3. Solid phase extraction (SPE) 
The target compounds were extracted from the filtered water samples using SPE. The Oasis 
SPE cartridges (0.2 g HLB, Waters) were conditioned with 5 mL of ethyl acetate to remove 
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residual bonding agents, followed by 10 mL of methanol which was drawn through the 
cartridges under a low vacuum to ensure that the sorbents were soaked in methanol for 5 
min. Ultrapure water (3 x 5 mL) was then passed through the cartridges at 1-2 mL/min. 
Water samples were then extracted at approximately 10 mL/min
 
as this has been shown to 
be the most efficient. The SPE cartridges were subsequently dried under vacuum and the 
extracts eluted from the sorbents into 20 mL vials with 10 mL of methanol at a flow rate of 
1 mL/min. The solvent was then blown down to 100 μL under a gentle N2 flow and ready 
for analysis. 
6.2.4. Sample analyses by LC-MS/MS 
The LC separation was carried out with a Waters 2695 HPLC separations module, 
manufactured by Waters (Milford, MA, USA), which was fitted with a Waters Symmetry 
C18 column (4.6×75 mm, particle size 3.5 μm). The LC-MS/MS methods used here are 
discussed briefly and are described fully in chapter 3. The mobile phase comprised eluent A 
(ultrapure water), eluent B (acetonitrile) and eluent C (methanol). Flow rate was 0.2 
mL/min and the elution started with 10% of eluent B, followed by a 25 min gradient to 
80% of eluent B and a 3 min gradient to 100% of eluent B, and then changed to 100% of 
eluent C within 8 min, held for 10 min and then returned back to the initial conditions 
within 4 min.  The system re-equilibration time was 10 min and the sample injection 
volume was 10 μL. The MS-MS analyses were completed with a Micromass Quattro triple-
quadrupole mass spectrometer equipped with a Z-spray electrospray interface. The analyses 
for steroidal estrogens were done in the negative ion mode. The electrospray source block 
and desolvation temperature were 100 and 300ºC, respectively; capillary and cone voltages 
were 3.0 kV and 30V, respectively; argon collision gas 3.6×10
-3
 mbar; cone nitrogen gas 
flow and desolvation gas: 25 and 550 L/h. Following the selection of the precursor ions, 
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product ions were obtained at optimum collision energies and were selected according to 
the fragmentation that produced a useful abundance of fragment ions. The optimal collision 
energy, cone voltage and transitions chosen for the multiple reaction monitoring (MRM) 
experiment were optimized and utilized a dwell time of 100 ms. The mass spectrometer 
was operated in MRM mode with unit mass resolution on both mass analyzer. 
 
6.3. Results and discussion 
6.3.1. Concentration of steroidal estrogens in STW effluent 
As the source of inputs for EDCs and PPCPs in the river systems, the STW effluent was a 
focus of this research in terms of sampling and analysis. Initial observations during the 
filtration of post-GAC effluent water showed a significant reduction in the amount of 
suspended particulate matter in samples. This was subsequently quantified and a ∼10-fold 
reduction was observed in all effluent samples (mean pre-GAC of 0.05 g L
−1
 compared 
with a mean post-GAC of 0.006 g L
−1
). 
From the measurement of EDC concentration in the effluent samples, it is clear that a 
significant reduction in the concentrations of E1, E2 and EE2 in effluent samples was 
observed. Prior to GAC installation, the measured concentration range for each compound 
was 0.6–3.1 ng L−1, <1.2–5.4 ng L−1 and <0.4–1.7 ng L−1 for E1, E2 and EE2, respectively. 
After GAC installation, the measured concentration range for E1 fell to <0.6–2.0 ng L−1. 
Concentrations of E2 and EE2 were below the method limit of detection (LOD) of 1.2 ng 
L
−1
 and 0.4 ng L
−1
, respectively, in all samples. 
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Table 6.3. Concentration ranges of steroidal estrogens and pharmaceutical compounds in 
STW effluent pre- and post-GAC installation 
 As is shown in Table 6.3, a significant reduction in the concentrations of E1, E2 and EE2 
in effluent samples is observed, this is further highlighted in Figs. 6.3. Accordingly, a 
significant reduction in the calculated estrogenicity, a key parameter used in assessing the 
risk posed by estrogenic pollutants, represented by E2 equivalence (EEQ), of effluent is 
observed, as is shown in Fig. 6.3(b). EEQ, based on the potency of each steroid in reference 
to E2, is calculated as follows: EEQ = CE2 + ⅓ CE1 + 10 CEE2  (6-1) 
where CE2, CE1, and CEE2 represent the concentrations of E2, E1 and EE2, respectively. 
 
Compound Pre-GAC effluent (ng/L) Post-GAC effluent (ng/L) 
E1 0.6 – 3.1 <0.6 – 2.0 
E2 <1.2 – 5.4 <1.2 
EE2 <0.4 - 1.7 <0.4 
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Fig. 6.3 Comparison of the pre- and post-GAC effluent samples for: (a) mean 
concentrations of steroidal estrogens, (b) temporal variability of measured total steroidal 
estrogens, and (c) temporal variation of estrogenic activity represented by EEQ. Error bar = 
one standard deviation. Symbols ** and * represent P values of <0.01 and <0.05, 
respectively. 
Prior to GAC installation, the measured concentration range for each compound is 0.6-3.1 
ng/L (mean 2.2 ng/L), <1.2-5.4 ng/L (mean 2.1 ng/L) and <0.4-1.7 ng/L (mean 0.7 ng/L) 
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for E1, E2 and EE2 respectively. The EDC concentrations changed with time during the 24-
h periods, as shown in Figure 6.3(b). The total EDC concentrations (E1 + E2 + EE2) ranged 
from 3.6 ng L
−1
 at 14:00 to 7.1 ng L
−1
 at 22:00, suggesting increased discharge of 
estrogenic compounds at the end of a working day before GAC was installed. Following 
GAC installation, the variability of EDC concentrations was less obvious (relative standard 
deviation (RSD) = 17% for E1, and 0% for both E2 and EE2), primarily because most of 
the EDCs had been removed by the improved GAC technology. 
After GAC installation, the measured concentration range for E1 fell to <0.6-2.0 
ng/L (mean 0.8 ng/L). Concentrations of E2 and EE2 were below the method limit of 
detection (LOD) of 1.2 ng/L and 0.4 ng/L respectively, in all samples. This reflects a mean 
percentage reduction in concentrations by 63% of E1, and a reduction of at least 25% of E2 
and EE2, suggesting a major improvement in the removal of EDCs from sewage effluent 
with the GAC plant.  
As shown in Figure 6.3(b) EEQ concentrations varied from 2.2 to 14.6 ng L
−1
 before GAC, 
with the maximum value being detected at 14:00 which is primarily due to the highest EE2 
concentration (1.3 ng L
−1
) then. It is expected that there would be a time lag between the 
use of EE2 (as the main component of oral contraceptive pills) and the time it was found in 
sewage effluent, due to transport and residence in sewerage and sewage systems. Following 
GAC treatment, the EEQ values were reduced to ≤0.5 ng L−1. Such major reductions are 
due primarily to the complete removal of EE2, which contributes most to the EEQ values. 
6.3.2 Concentrations of steroidal estrogens downstream of STW effluent 
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Fig. 6.5 shows that, as expected, since sewage effluent is recognized as the predominant 
source of environmental estrogens in natural waters, the reduction in the measured 
concentrations of the steroidal estrogens observed in sewage effluent is reciprocated in the 
receiving river. Fig 6.5 also shows predicted downstream concentrations for the steroidal 
estrogens and the pharmaceutical compounds, respectively, using the simple dilution 
model, as has been discussed in previous publications [12][31]: 
DW
EFEFUWUW
DW
V
VCVC
C

   (6-2) 
where CEF, CUW, CDW are the pollutant concentrations in the STW effluent, upstream and 
downstream. VEF, VUW and VDW represent the flow rates in the effluent, upstream and 
downstream. 
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Fig. 6.4. Measured and predicted concentrations of: (a) steroidal estrogens and (b) 
pharmaceutical compounds 1.7-km downstream of the STW effluent, before and after GAC 
operation. Error bar = one standard deviation. 
Good agreement between measured and predicted concentrations was observed, particularly 
for the steroidal estrogens. For pharmaceuticals, the model prediction was excellent for 
propranolol, and still good for carbamazepine. Overall, however, the model tended to 
underestimate by between 5 and 28% for those compounds that were also detected by 
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chemical measurement. On the other hand, the model predicted the presence of 
indomethacine and diclofenac at concentrations significantly above the method LOD in the 
receiving river water in pre-GAC samples, which differed from the observed non-detectable 
concentrations through measurement. The model however subsequently predicted these 
compounds would not be present in post-GAC samples, in agreement with the measured 
results. The model also predicted low concentrations (ng L
−1
) of mebeverine in the 
receiving river waters after GAC commission, which is an over-estimate in comparison to 
the measured results. Overall, the dilution model has provided a reasonable prediction of 
the measured EDC and pharmaceutical concentrations, demonstrating the importance of 
STW effluents as a point source of such compounds into the aquatic environment. 
6.3.3. Concentration of PPCPs in STW effluent 
It has been widely reported that the removal of pharmaceuticals during conventional 
sewage treatment is incomplete, sometimes as low as close to zero [13], [27] and [28]. Of 
the 11 pharmaceutical compounds analysed, only five (propranolol, mebeverine, 
carbamazepine, indomethacine and diclofenac) were detected in pre-GAC effluent samples, 
and only three (propranolol, mebeverine, carbamazepine) were detected in post-GAC 
effluent samples. The concentrations of pharmaceuticals varied from 7.6 ng L
−1
 for 
indomethacine, to 79.7 ng L
−1
 carbamazepine, in pre-GAC effluents. In a study of three 
STWs in Ohio, USA, Spongberg and Witter [29] detected 34–111 ng L−1 of carbamazepine 
in sewage effluents, which is comparable to the pre-GAC concentrations found in this 
study. In addition, the concentrations of carbamazepine in the effluent samples are 
significantly lower than those found elsewhere, with Kasprzyk-Hordern et al. [28] reporting 
concentrations up to 3117 ng L
−1
 in the effluent of a STW in Cilfynydd, Wales and Zhou et 
133 
 
al. [12] detecting 233–1061 ng L−1 in the effluent of a STW in West Sussex, UK. For other 
pharmaceutical compounds, pre-GAC concentrations are broadly comparable to other 
studies, albeit at the lower-end of reported concentrations, such as 6–35 ng L−1 for 
indomethacine [12] [30]. 
The pharmaceutical concentrations were substantially reduced in post-GAC effluents, 
varying from <LOD for indomethacine and diclofenac to 47.6–58.4 ng L−1 for 
carbamazepine. On average, the additional removal of pharmaceuticals by GAC was 
between 17% for propranolol to >98% for indomethacine (Fig. 6.6a). These reductions are 
broadly comparable to results derived from laboratory testing using activated carbon. The 
concentrations of pharmaceuticals also varied diurnally, as shown during the 24-h sampling 
(Fig. 6.6b). Mebeverine varied from 33.39 to 41.5 ng L
−1
 in pre-GAC effluents and 5.0–7.4 
ng L
−1
 in post-GAC effluents. The total concentrations of all measured pharmaceuticals did 
not vary as significantly as EDCs during either 24-h period, but similarly a peak of the total 
measured pharmaceutical compounds of 201.8 ng L
−1
 at 22:00 in pre-GAC samples was 
observed, with even less variability in post-GAC effluents (RSD = 3.9%). 
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Fig. 6.5. Comparison of the pre- and post-GAC effluent samples for: (a) mean 
concentrations of pharmaceutical compounds and (b) temporal variability of measured total 
pharmaceutical concentrations. Error bar = one standard deviation. Symbols ** and * 
represent P values of <0.01 and <0.05, respectively. 
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6.3.4 Variability of steroidal estrogens throughout the catchment 
To fully appreciate the environmental occurrence and persistence of emerging contaminants 
in river water, as well as the added benefit of GAC installation, a systematic sampling and 
analysis of STW effluent and river water were undertaken. Results (Fig. 6.6) show the 
concentrations of E1, E2 and EE2 at four sites in the receiving river, including one 
upstream and three downstream sites, as well as at a control site over a three-year period. 
The results demonstrate a clear reduction in the average concentrations from 3.2 ng L
−1
 
(pre-GAC) to <0.6 ng L
−1
 (post-GAC, 81% reduction) for E1, 3.8 ng L
−1
 to <1.2 ng L
−1
 (at 
least 68% reduction) for E2, and 0.8 to <0.4 ng L
−1
 (at least 50% reduction) for EE2 
downstream of the effluent, after the installation of the GAC plant. However, there appears 
to be a lag between the reduction in effluent concentrations and the apparent non-presence 
of E1 and E2 in the receiving river water, with a small amount of these compounds present 
in downstream samples some months after installation of the GAC. This is likely due to 
pre-existing amounts of these compounds from pre-GAC effluent taking some time to 
degrade. There appears to be no such lag for EE2, which was not detectable in any sample 
from the catchment after installation of the GAC. 
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Fig. 6.6. Concentrations of E1, E2 and EE2 across the catchment over the three year period. 
Site 1 = 3.5 km upstream, site 2 = 10 m downstream, site 3 = 1.7 km downstream, site 4 = 
8.3 km downstream, site 5 = control site. Error bar = one standard deviation. 
6.4 Comparisons with in-vitro analytical and computer modeling techniques 
As part of the Defra-sponsored EDCAT project, the results of the chemical analysis of spot 
water sample as discussed previously were compared with those obtained by Yeast 
Estrogen-Screening (YES) assays as developed by Routledge & Sumpter (1996) [32], of 
spot samples and passive, integrated samples (T=28 days) collected using  Polar Organic 
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Contaminants Integrated Sampling (POCIS) devices as developed by Alvarez et. Al. (2004) 
[334], performed by colleagues at Cefas, as well as with predictions made using the 
Exposure Analysis Modeling System (EXAMS) model, developed by the US EPA [34][35] 
but adapted and used by colleagues at the CEH [36].  
 
Figure 6.7 Comparison of average EEQ concentrations determined from chemical 
analysis of water extracts followed by calculation using Eq. (2), YES measurement 
of water extracts, and YES measurement of POCIS extracts. N = 165. Error bars 
represent standard deviations. 
 
Annual average data for estrogenic activity calculated from the chemical analysis of water 
samples are shown in Fig. 6.7, together with estrogenic activity determined by YES 
analysis of spot water and POCIS extracts. It is apparent that although there is generally 
good agreement of the three techniques with regard to them all showing a clear reduction in 
detected estrogenic activity after the GAC was commissioned, EEQ values from chemical 
analysis of spot samples tend to be greater than those determined by YES of either spot or 
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passive water samples. Such differences between YES and chemical analysis may be 
ascribed to the following factors: 
 
 The YES assay is recognized to be only semi-quantitative, with Huggett et al. 
(2003) [37] suggesting it may underestimate in vivo estrogenic activity by 10-fold. 
 The limit of detection by chemical analysis (between 0.4 and 1.2 ng L
−1
) is higher than 
that by YES assay (0.02 ng L
−1
). Thus, during the analysis of very low levels of EDCs 
(i.e. <0.1 ng L
−1
), chemical analysis will be less sensitive to small differences between 
samples than YES assay. As a result, the measurement errors from chemical analysis 
will be potentially greater than from YES. 
 For the analysis of EE2, Young et al. (2004) recommend a confidence interval of 
0.01 ng L
−1
 which is not achievable with current analytical techniques. By definition, 
the EEQ formula (Eq. (2)) will inflate errors in the analysis of EE2, where errors of 
1 ng L
−1
 or even 0.1 ng L
−1
 may at first seem insignificant, these can cause large 
overestimates of EEQ (i.e. of 10 or 1 ng L
−1
 respectively). 
 Young et al. (2004) recognised intrinsic uncertainty in the EEQ formula due to the 
precautionary principle, as the derived PNEC values (upon which Eq. (2) is based) are 
only a conservative estimate based on toxicological data available at the time. For 
example, for E1, they reported a scarcity of toxicological results but suggested a PNEC 
of 3–5 ng L−1. The contributions of each compound to overall EEQ are also based on 
in vivo rather than in vitro data 
 There may be contributions in the YES assay from antagonists, which would reduce 
the overall EEQ values measured. 
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Figure 6.8 Comparison of modelled and measured E1 and E2 concentrations along the 
River Ray using effluent data calculated from Johnson and Williams (2004) [39]. The dots 
are the measured data and the lines are the modelled data for June 2007. 
Figure 6.8 shows a comparison of measured concentrations of E1 and E2 with those 
calculated uising the EXAMs model using as its starting point a predicted estrogen 
discharge for the Rodbourne STW. This prediction was based on the population equivalents 
and the removal in sewage treatment typical of a secondary treatment works, calculated 
using the method of Johnson and Williams (2004) [39]. Simulations were compared with 
measured data for the months of April, June and September. The figure shows the data 
generated for June compared to measured E1 and E2 concentrations. Starting from these 
STW input the model predicted higher than observed values for E1 and lower than 
observed values for E2. Thus, the performance of Rodbourne STW was different from that 
of many STWs reviewed previously [39][40][41]. These previous observations have shown 
that E2 removal usually exceeds that of E1, and one would therefore expect to see relatively 
higher effluent concentrations of E1 compared to E2. 
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Figure 6.9 Comparison of modelled and measured E1 and E2 concentrations along the 
River Ray using effluent data calculated from Johnson and Williams (2004). The dots are 
the measured data and the lines are the modelled data for June 2007. 
The EXAMS model was subsequently updated to use the effluent values as shown in figure 
6.5 and compared with modelled predicted values in table 6.4. These data fit closely with 
those derived from the model of Johnson and Williams (2004) [39] for E2 and for EE2, 
although the E1 measured concentrations were still lower than the modelled predictions 
Values were also similar to those obtained using POCIS samplers and testing using the 
yeast estrogen screen. The data suggest, as discussed, that the removal from the STW was 
around 93% for E1 (compared to a value of 65% used in the model) based on the predicted 
input from the population served. The predicted estrogen input relies on the known human 
population served by the STW, its assumed excretion and the flow [39]. This unexpectedly 
high performance could be due to the biological nutrient removal (BNR) facility at the 
STW, which may be particularly effective at removing E1. Figure 6.9 shows predicted 
concentrations of E1 and E2 using the updated model, compared with concentrations 
determined by chemical analyses. This simulation of downstream concentrations provided a 
better fit with the observed values for both E1 and E2. For modelling this demonstrates the 
importance of calibrating the initial discharge with measured values. 
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Compound Predicted 
concentration 
(ng/L) 
Predicted overall 
estrogenicity (E2 
equiv ng/L) 
Range of 
measured 
values (ng/L) 
Overall calculated 
estrogenicity (E2 
equiv ng/L) 
E1 19.0 15.8
a
 1.0 to 3.0 7.3–9.3b 
E2 2.5  1.3 to 4.6  
EE2 0.7  < 0.4 to 1.3  
a
Calculated using E2 equivalents [38] 
b
 Assuming either 0 (lower end) or 0.4 (higher end) for the non-detected EE2 values. 
 
Table 6.4 Comparison between concentrations in the Swindon STW measured in February 
2008 and predictions by the model 
 
6.5. Conclusions 
A significant reduction in the concentrations of three key steroidal estrogens in sewage 
effluents as measured by chemical analysis, and subsequently in the receiving river waters, 
has been observed as a result of the installation of GAC as a post-tertiary sewage treatment 
process. This concurs with the findings of analysis of spot and integrated samples analysed 
independently using YES screens. However, both chemical analysis and analysis by YES 
screening suggest the overall mix and concentrations were significantly below those 
predicted by the EXAMS model and below those of studies of other STWs. It is plausible 
that the BNR process, believed to refer to biological phosphate removal in this case, which 
involves a prolonged biological treatment [42] may have led to this better than expected 
performance of the Rodbourne STW.  
 Whether these reductions are sufficient as to prevent endocrine disrupting effects in 
aquatic organisms on the longer term, however, remains to be confirmed. The reductions in 
the concentrations of pharmaceutical compounds are less clear, though some compounds 
are shown to be significantly removed, others are not, and removal appears to vary between 
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classes of pharmaceuticals. Moreover, GAC-based removal technology has been shown to 
be less efficient over time for some classes of organic pollutant, including phenolic 
endocrine disrupting chemicals. As of yet, the long-term efficacy of GAC for the removal 
of steroidal estrogens is not understood, and existing analytical procedures are unable to 
detect and resolve concentrations of E2 or EE2 at concentrations likely to be present in 
post-GAC effluents. Analytical research should focus on the reduction of detection limits 
so that the behaviour of steroidal estrogens at these concentrations can be better understood. 
Cost implications will also feature as a major driver in future investigations.  
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Chapter 7. A The occurrence of pharmaceutical residues in water, sediment, 
wastewater and colloids and their removal by sewage treatment processes  
7.1 Introduction  
Pharmaceuticals are a class of emerging environmental pollutants that are widely used both 
in human and veterinary medicine. They are known to be ubiquitous in the environment, as 
many pharmaceuticals have been detected in wastewater treatment works (STW) effluents, 
surface water and groundwater worldwide [1], [2], [3] and [4]. There is limited data 
available on bioaccumulation of drug residues in organisms [3] and only a few specific 
cases have emerged to date showing the serious impact pharmaceuticals can have on 
wildlife. In India and Pakistan, a common vulture species suffered a severe population 
collapse, which was suggested to be caused by an analgesic and anti-inflammatory drug, 
diclofenac. The drug was regularly used for veterinary medication and residues entered the 
vultures as they fed on dead domestic livestock, causing renal failure and resulting in an 
over 95% decline in some populations since early 1990s [5]. Another study found the same 
drug to cause vitellogenin induction in male Japanese medaka (fish) at environmentally 
relevant concentrations of just 1 μg L−1 [6]. Although evidence is limited, it is clear that 
pharmaceuticals have the potential to cause serious harm to wildlife and also to humans. 
The main route to the environment for pharmaceuticals is through discharged effluent from 
STW as a result of excretion from humans and animals, as well as from domestic disposal 
of medicinal products [3]. The concerning issue with pharmaceuticals is not their acute 
toxic effects but their chronic toxicity. These compounds are commonly present at low 
levels throughout the lifecycle of many aquatic organisms and are particularly important for 
Sediment particles 
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those living in waters receiving sewage effluent (e.g. rivers). These chemicals are persistent 
and/or biologically active and designed to target a specific metabolic or molecular pathway. 
Pharmaceuticals generally are biologically active compounds that are intended not to be 
easily biodegradable and are often water soluble and therefore can be found in wastewaters 
and can easily end up in natural waters [7]. Potentially, they could have a similar function 
or cause side effects in non-target organisms as they do in their intended users. Thus, a 
good understanding of the pharmaceutical concentrations present in treated sewage 
effluents and their receiving river water and the rate of removal of these compounds during 
STW is a necessity for improving the knowledge of their fate in the environment.  
The work discussed in this chapter aims to determine the concentrations of a range of 
pharmaceuticals in the different stages of treatment in two STWs in the UK (Table 7.1), to 
identify the most effective treatment technology for degrading pharmaceutical residues. 
Secondly the concentrations of pharmaceuticals in their receiving rivers will be compared 
against their concentrations in effluent, so as to assess the importance of STW as a source 
of pharmaceuticals in rivers. Finally, the potential toxicological impacts of pharmaceuticals 
on the aquatic organisms in these rivers will be evaluated. 
Table 7.1. Operational characteristics of the UK STWs used in this study 
STW County Treatment 
technology 
Population 
covered 
Population 
equivalent 
(PE) 
Typical 
flow rate 
(L s
−1
) 
Scaynes West Primary 22 000 162 619 230 
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Hill Sussex sedimentation, then 
lagoon. Secondary 
treatment only. 
Rodbourne Swindon Primary 
sedimentation, 
aeration, secondary 
sedimentation, 
GAC*.  
155 000  18 320 570 
 
*Commissioned February 2008 
7.2. Experimental 
7.2.1. Chemicals and materials 
All the solvents used including methanol and acetonitrile, purchased from Rathburn, were 
of distilled-in-glass grade. Formic acid was of high performance liquid chromatography 
(HPLC) grade. Propranolol, sulfamethoxazole, meberverine, thioridazine, carbamazepine, 
tamoxifen, mecoprop, indomethacine, diclofenac, meclofenamic acid and monensin were 
purchased from Sigma, UK. These target compounds were chosen based on their high risk 
characterisation ratio [8], quantity of chemicals used per year, reported occurrence 
worldwide, and availability of an analytical method. The pharmaceutical internal standards 
(diuron-d6 and 
13
C-phenacetin) were supplied by Cambridge Isotope Laboratories, USA. 
Stock solutions of all standards (1000 mg L
−1
) were prepared from which working 
standards solutions (10 mg L
−1
) were made. All standards and internal standards were 
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prepared in methanol and stored in a freezer at −18 °C. Ultrapure water was from a Maxima 
Unit supplied by USF Elga, UK. Sodium azide, silica gel (0.063–0.2 mm) and aluminium 
oxide (0.05–0.15 mm, neutral) were purchased from Sigma–Aldrich Company Ltd., UK. 
The Oasis
®
 HLB solid-phase extraction (SPE) cartridges (6 mL/200 mg) were obtained 
from Waters Ltd., UK. 
7.2.2. Sampling and sample treatment 
Samples were taken at the three STWs used for this study. For the Scaynes Hill STW, 
samples were taken at the influent inlet (influent, IN), after primary treatment (humus tank, 
HU), after secondary treatment (lagoon, LA), and at the effluent pipe (effluent, EF) in 
November 2006. For the Manor Farm Road STW, samples taken included raw wastewater, 
and effluents of primary sedimentation and humus tanks. For the Basingstoke STW, 
samples were taken at the influent, after sedimentation, after activated sludge process and 
after sand filtration. In addition, water samples were taken from the river Ouse upstream of 
the Scaynes Hill STW (UW), and downstream from the STW (DW) to assess the impact of 
STW effluent on downstream water quality. Sodium azide (10 mL, 2 M) was added to each 
sample on site as a general biocide to eliminate bacteria and prevent sample degradation 
during storage and processing. The samples were stored in a refrigerator below 4 °C until 
filtration and extraction. Along with the water samples, a series of measurements were 
taken for the water quality including pH (7.0–8.2), conductivity (328–1042 μS), dissolved 
oxygen (1.0–10.9 mg L−1), temperature (8.2–15.2 °C) and redox potential (−280–134 mV). 
The samples (1 L) were filtered under vacuum through pre-ashed glassfibre filters 
(Whatman, GF/F). The filtrates were spiked with 100 ng of internal standards. 
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The discharge flow rates of effluent from the Scaynes Hill STW for the period when 
sampling was taking place, were obtained from the operator (Southern Water), which 
varied between 73 and 76 L s
−1
. The flow rates for the River Ouse were obtained from the 
Environment Agency, which were measured at Ardingly Weir, approximately 9 km 
upstream of the outfall, and at Gold Bridge in Newick, approximately 8 km downstream of 
the outfall. 
7.2.3. Sample extraction and clean-up 
Filtered water samples were extracted using a SPE system from Supelco, following an 
established procedure [9]. The Oasis HLB (Waters) cartridges were conditioned with 
10 mL of methanol, followed by ultrapure water (3 mL × 10 mL) at a rate of 1–2 mL min−1. 
Then, water samples were at a flow rate of 5–10 mL min−1. Afterwards the cartridges were 
dried for 30 min under full vacuum, with the analytes being eluted to 20 mL glass vials 
from the sorbents with 10 mL of methanol. The solvent was reduced to 0.1 mL under gentle 
N2 flow. 
Due to the complex nature of the wastewater samples, an additional clean-up step was 
required to remove the interfering species and particulate matter that could block and 
damage the HPLC column, and produce false mass spectrometry (MS) signals in the 
samples. All wastewater extracts were treated with silica:alumina (1:1) columns after N2 
blow-down. Glass columns (5 mL) were filled with ashed and deactivated silica–alumina 
(1:1) powder with ashed quartz wool used as stoppers at the top and bottom of the column, 
to which samples were added and eluted with 10 mL of methanol. N2 blow-down was used 
again to reduce the sample size back to 100 μL. All the sample extracts were transferred to 
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VectaSpin Micro centrifuge filters (0.2 μm, Whatman) and centrifuged at 7000 rpm for 
10 min in order to further remove particulate matter. The extracts were further concentrated 
under N2 blow-down to 100 μL ready for analysis. 
7.2.4. Sample analyses 
Liquid chromatography–tandem mass spectrometry (LC–MS–MS) coupled with 
electrospray ionisation was used for sample analysis, following a method developed by 
Zhang and Zhou [9]. The LC separation was carried out with a Waters 2695 HPLC 
separations module, manufactured by Waters Corporation (Milford, MA, USA), which was 
fitted with a Waters Symmetry C18 column (4.6 mm × 75 mm, with particle size 3.5 μm). 
The mobile phase comprised eluent A (with 0.1% formic acid in ultrapure water), solvent B 
(acetonitrile) and eluent C (Methanol). Flow rate was 0.2 mL min
−1
 and the elution started 
with 10% of eluent B, followed by a 25 min gradient to 80% of eluent B and a 3 min 
gradient to 100% of eluent B, and then changed to 100% of eluent C within 8 min, held for 
10 min and then returned back to the initial conditions within 4 min. The system re-
equilibration time was 10 min and the sample injection volume was 10 μL. 
The MS–MS analyses were completed with a Micromass Quattro triple-quadrupole mass 
spectrometer equipped with a Z-spray electrospray interface. The analyses were done in the 
positive ion mode. The parameters for the analysis were: electrospray source block and 
desolvation temperature were 100 and 300 °C, respectively; capillary and cone voltages 
were 3.0 kV and 30 V, respectively; argon collision gas 3.6 × 10
−3
 mbar; cone nitrogen gas 
flow and desolvation gas: 25 and 550 L h
−1
. Following the selection of the precursor ions, 
product ions were obtained at a series of collision energies and were selected according to 
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the fragmentation that produced the highest abundance of fragment ions. The optimal 
collision energy, cone voltage and transitions chosen for the multiple reaction monitoring 
(MRM) experiment were optimised and a dwell time of 100 ms was used. The mass 
spectrometer was operated in MRM mode with unit mass resolution on both mass 
analysers. 
7.2.5. Analytical quality controls 
All data were subject to strict quality control procedures, including the analysis of 
procedural blanks and spiked samples with each set of samples analysed. None of the target 
compounds were detected in the procedural blanks. Spiked water samples (100 ng of each 
target compound) in river (Ouse), influent and effluent matrices (Scaynes Hill STW) were 
determined with good precision and recoveries. The limit of detection (LOD), mean 
recovery and relative standard deviation (RSD) of our analytical method for 
pharmaceuticals in water have been reported [9]. Briefly, the LOD of target compounds 
ranged from 1 to 288 pg L
−1
 in river water, and between 0.05 and 5 ng L
−1
 in wastewater 
samples. The recovery of most compounds is high (71–95%) except for tamoxifen (52%) 
and thioridazine (9%) in river water, and from 73 to 107% (except tamoxifen at 55% and 
thioridazine at 11%) in effluent, and 66–115% (except tamoxifen at 48% and thioridazine at 
15%) in influent samples. The precision is also good, with RSD < 20% for all compounds. 
The internal standards diuron-d6 and 
13
C-phenacetin were used to compensate for losses 
involved in the sample extraction and work-up, to further improve the analytical quality. 
7.3. Results and discussion 
7.3.1. Pharmaceuticals in STWs 
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The target pharmaceutical compounds were analysed in wastewater from Scaynes Hill 
STW daily. Of the eleven compounds, meberverine, thioridazine, mecoprop and 
meclofenamic acid were all below their LOD in both wastewater and river water samples, 
suggesting their limited use in the UK. Tamoxifen was detected in 100% of wastewater 
samples, at 0.1–1.3 ng L−1 in influent and 0.1–0.5 ng L−1 in effluent samples, although it 
was not found in river samples. In comparison, the remaining five compounds (propranolol, 
sulfamethoxazole, carbamazepine, indomethacine and diclofenac) were detected in all 
water and wastewater samples (Fig. 7.1), suggesting their widespread and frequent use, and 
some level of persistence in the environment. According to the National Health Service, the 
quantity of the five substances dispensed in England in 2006, in primary care (excluding 
hospitals and retailers), varied from approximately 1 ton for sulfamethoxazole and 
indomethacine to 40 ton for carbamazepine. Similar to Scaynes Hill STW, the five 
compounds were detected in all samples in Manor Farm Road STW. Their concentrations 
varied from 65 to 1237 ng L
−1
 in influent, and from 27 to 345 ng L
−1
 in effluent. Slightly 
higher concentrations of these compounds were found in Basingstoke STW, with their 
concentrations ranging from 124 to 1833 ng L
−1
 in influent, although similar concentrations 
(14–233 ng L−1) were observed in effluent samples. 
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Fig. 7.1. The daily trend of pharmaceutical concentrations through the different treatment 
stages in Scaynes Hill STW. IN, influent; HU, humus tank; LA, lagoon; EF, effluent. 
Table 7.2 shows the concentrations determined by analyis of samples collected in the areas 
studied in this work, compared to the concentrations determined by other researchers 
internationally. As can be seen, concentrations propranolol, sulfamethoxazole, 
carbamazepine, indomethacine and diclofenac varied greatly from 24 to 2336 ng L
−1
 in 
influent, such a major difference in concentrations between different compounds has also 
been reported by Bendz et al. [10] in Källby STW in Sweden. The concentration of 
propranolol (100–1090 ng L−1) is similar to 542 ng L−1 found in Cilfynydd STW in Wales 
[11]. The concentrations of sulfamethoxazole (24–181 ng L−1) and diclofenac (107–
981 ng L
−1
) are also comparable to those reported in STW effluents in Canada [12], Ohio, 
USA [13] and Soseigawa, Japan [14]. Carbamazepine levels are similar to those found in 
Källby STW, Sweden and Cilfynydd STW in Wales, but significantly higher than those in 
Ohio. 
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Pharmaceuticals concentrations (single value, min–max, or mean ± SD) in wastewater 
samples worldwide. 
Pharmaceutical 
 
STW 
 
Influent 
(ng L
−1
) 
 
Effluent 
(ng L
−1
) 
 
Apparent 
removal (%) 
 
Reference 
 
Propranolol 5 STWs, 
England 
 16–284  [8] 
 Cilfynydd, 
Wales 
542 388 28% [11] 
 Käl by, 
Sweden 
50 30 32% [10] 
 7 STWs, New 
Mexico, USA 
 32–77  [17] 
 Sheffield Park 
STW, England 
100–1090 20–72 80–90% [16] 
 3 STWs, 
England 
 16–135  This study 
 
Sulfamethoxazole 8 STWs, 
Canada 
 Up to 871  [12] 
 5 STWs, 
England 
 <50–132  [8] 
 Källby, 
Sweden 
20 70 0% [10] 
 Cilfynydd, 
Wales 
<3 12 0% [11] 
 Ohio, USA 14–261 79–472  [13] 
 7 STWs, New 
Mexico, USA 
 98–2200 53–82% [17] 
 Sheffield Park 
STW, England 
24–181 12–25  [16] 
 3 STWs, 
England 
 8–37  This study 
 
Carbamazepine Källby, 
Sweden 
1680 1180 30% [10] 
 Cilfynydd, 
Wales 
2593 3117 0% [11] 
 Ohio, USA 25–51 34–111  [13] 
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 7STWs, New 
Mexico, USA 
 70–800 43–54% [17] 
 Sheffield Park 
STW, England 
1237–2336 399–652  [16] 
 3 STWs, 
England 
 233–1061  This study 
 
Tamoxifen 5 STWs, 
England 
 42  [8] 
 3 STWs, 
England 
0.2–1.5 0.2–0.7 32–45% This study 
 
Indomethacine Sheffield Park 
STW, England 
 6–9  [16] 
 3 STWs, 
England 
46–124 9–35 61–89% This study 
 
Diclofenac 49 STWs, 
Germany 
 Up to 
2100 
 [1] 
 5 STWs, 
England 
 <2 –2349  [8] 
 Källby, 
Sweden 
160 120 22% [10] 
 oseigawa 
municipal, 
Japan 
251 ± 100 145 ± 32  [14] 
 Cilfynydd
Wales 
70 123 0% [11] 
 Ohio, USA <1–14 8–32  [13] 
 Sheffield Park 
STW, England 
 49–85 70–92% [16] 
 3 STWs, 
England 
107–981 37–176  This study 
Table 7.2 Influent and Effluent concentrations of selected pharmaceuticals in STW in 
different countries compared with those in this study. 
With each stage of wastewater treatment in Scaynes Hill STW, the concentrations of the 5 
compounds showed a gradual decrease. Similar to influent, the concentrations of individual 
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compounds in the STW effluent also varied significantly during the five day sampling 
period, with RSD values varying from 23% for carbamazepine to 50% for 
sulfamethoxazole. However, Jones et al. [15] found that the pharmaceuticals (paracetamol, 
salbutamol, ibuprofen and mefenamic acid) entering and leaving an activated sludge STW 
did not show major changes. Zhang et al. [16] also found that the same 5 compounds being 
studied here did not vary significantly in their concentrations in effluent from Sheffield 
Park STW, West Sussex, UK. 
Overall, the concentrations of propranolol in the effluents from the three STWs (16–
135 ng L
−1
) are comparable to 16–388 ng L−1 detected in other UK STWs, 30 ng L−1 in 
Källby STW in Sweden, and 32–77 ng L−1 in New Mexico, USA. Sulfamethoxazole was 
detected in 100% of effluent samples at the concentrations of 8–37 ng L−1. In comparison, 
sulfamethoxazole was only detected in 9% of effluent samples in other UK STWs [8], 
albeit at similar concentrations (<50–132 ng L−1). Similar concentrations of 
sulfamethoxazole (70 ng L
−1
) were observed at Källby STW in Sweden [10], but 
significantly higher concentrations (up to 2200 ng L
−1
) have been determined in New 
Mexico, USA [17]. Carbamazepine was the dominating compound in terms of abundance 
in all stages of the wastewater treatment, consistent with similar findings in Sheffield Park 
STW [16]. Its concentrations in effluent varied between 233 and 1061 ng L
−1
, similar to 
1180 ng L
−1
 found in Källby STW in Sweden [10] and <1–6300 ng L−1 being reported in 
STW effluents worldwide [18]. Tamoxifen were detected at very low level (0.1–
0.7 ng L
−1
), which are significantly lower than those found in other UK STWs at up to 
42 ng L
−1
 [8]. 
7.3.2. Removal of pharmaceuticals during STW processes 
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As the wastewater was passed through the STWs there was typically a gradual reduction in 
the concentrations of pharmaceutical compounds being observed, as shown in Figure 7.2 
for Scaynes Hill STW. For example, primary sedimentation (humus tank) removed 24% of 
indomethacine, 26% of carbamazepine, 28% of sulfamethoxazole, 60% of diclofenac and 
69% of propranolol. By passing through a lagoon, a further reduction in concentration of 
between 0% for carbamazepine and 26% for indomethacine was made, suggesting that 
lagoon is a relatively inefficient secondary treatment method for pharmaceuticals. The 
overall removal efficiency for the pharmaceuticals was calculated from the following 
formula: 
    (1) 
where CIN and CEF are the daily pharmaceutical concentrations in the influent and effluent, 
respectively. 
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Fig. 7.2. Removal of five pharmaceutical compounds in the different stages of treatment in 
Scaynes Hill STW. Concentrations shown are the weekly mean in influent (IN), humus 
tank (HU), lagoon (LA) and effluent (EF). 
As shown in Table 7.3, the overall removal efficiency varied highly between compounds 
and between STWs. A clear feature common to all three plants is that the lowest removal 
was found for carbamazepine, varying from 43 to 54%, no matter which treatment 
processes were used. Secondly, the use of tertiary treatment at Basingstoke STW did show 
an improvement in the removal of all 5 compounds (from 54 to 92%) over the other two 
plants, suggesting that pharmaceutical residues can be removed more completely by 
investment in tertiary treatment. At Scaynes Hill STW, the removal efficiency ranged from 
43% for carbamazepine to 81% for propranolol. The mean concentration of propranolol 
was reduced from 334 ng L
−1
 entering the works to 62 ng L
−1
 in the final effluent; a 
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reduction of 81%. Similarly, the treatment works removed 61% of indomethacine present in 
the raw influent. 
Table 7.3. Weekly mean pharmaceutical concentrations in the influent and effluent of 
STWs and their apparent removal. 
Pharmaceuticals Scaynes  
Hill STW 
 
Manor Farm Road STW 
 
Basingstoke STW 
 
 CIN 
(ng
 L
−
1
) 
 
CEF 
(ng 
L
−1
) 
 
Remo
val 
(%) 
 
CIN  
(ng L
−
1
) 
 
CEF 
(ng L
−1
) 
 
Remo
val 
(%) 
 
CIN 
(ng L
−1
) 
 
CEF 
(ng L
−1
) 
 
Removal 
(%) 
 
Propranolol 334 62 81.4 690 135 80.4 1090 1 0 89.9 
Sulfamethox
azole 
49 23 52.7 110 37 66.4 181 32 82.3 
Carbamazepi
ne 
166
2 
950 42.8 1237 637 48.5 1833 837 54.3 
Indomethaci
ne 
62 24 60.8 65 19 70.8 124 14 88.7 
Diclofenac 397 119 70.1 782 176 77.5 981 78 92.0 
 
Lower removal efficiency of 22–32% has been reported for propranolol, carbamazepine 
and diclofenac at Källby STW in Sweden [10]. Many other previous studies have shown 
that the reduction of pharmaceutical compounds in STWs is often incomplete. In Brazil, 
removal for polar pharmaceutical compounds varied from 12 to 90% [19]. In Germany, 
reported reduction ranged from 10 to 90% [1], depending on the nature of the compounds. 
These reductions occurred in common tertiary treatment STWs, consisting of preliminary 
clarification followed by aeration and then finally endpoint clarification. To achieve non-
detectable concentrations of pharmaceutical residues, additional advanced treatment by 
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oxidation (e.g. ozonation at 10–15 mg L−1), activated carbon or membrane filtration is 
needed [20]. 
A further complication with pharmaceuticals is that although they may be removed by 
processes such as sedimentation and sand filtration, they are only temporarily stored in the 
sand particles by partitioning into the sludge component of the processes, which may be 
eventually sprayed in landfill sites, incinerated or amended to agricultural soils, posing 
potential threats to the environment. Only a complete degradation will provide a lasting 
solution to preventing pharmaceutical exposure to the environment. In addition, as no 
measurement was made of pharmaceutical concentration in sediments and sludge, the data 
did not reflect a full mass balance. Further work should also include the determination of 
pharmaceuticals in the particulate phase. 
7.3.3. Pharmaceuticals in the River Ouse 
In addition to sampling in Scaynes Hill STW, the concentrations of the pharmaceutical 
compounds in the river Ouse close to effluent discharge were measured. River water was 
sampled both upstream and downstream of the STW, to identify a potential source–sink 
relationship. Six compounds including meberverine, thioridazine, tamoxifen, thioridazine, 
monensin and meclofenamic acid were on average below the limit of detection at both river 
sites. The other compounds propranolol, sulfamethoxazole, carbamazepine, indomethacine 
and diclofenac were found in 100% of river samples (7.3 and b), consistent with their 
widespread occurrence in the STW. Their concentrations in river water were found to vary 
daily over the sampling period, with the exception of propranolol in upstream, confirming 
161 
 
the need for regular sampling and analysis in order to monitor pharmaceutical 
concentrations in rivers. 
Similar to wastewater samples, the highest concentrations were obtained for carbamazepine 
at 46–67 ng L−1 in upstream, to 167–334 ng L−1 in downstream. Significantly higher 
concentrations at up to 1100 ng L
−1
 have been detected in surface waters in Germany [2] 
and [18]. The lowest concentrations were shown by indomethacine at 0.2–0.9 ng L−1 in 
upstream, to 0.1–3 ng L−1 in downstream. Overall, a clear elevation in pharmaceutical 
concentrations is observed in the downstream over upstream, indicating that the Scaynes 
Hill STW is a source of pharmaceutical inputs to the river Ouse. 
To make a more quantitative estimation of the STW as a source of pharmaceuticals in the 
river Ouse, the concentrations of pharmaceuticals in the downstream of effluent discharge 
site were estimated using a simple dilution model assuming the mass balance being 
observed: 
     (2) 
 
where CDW and CUW are pharmaceutical concentrations in downstream and upstream, while 
VUW, VDW and VEF are the flow rates in upstream, downstream and effluent, respectively. 
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Fig. 7.3. Daily variation of pharmaceutical concentrations in the upstream (a) and 
downstream (b) of Scaynes Hill STW outfall in the River Ouse. Concentrations in the 
downstream were also predicted (c) using Eq. (2). UW, upstream; DW, downstream. 
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As shown in 7.3c, the predicted pharmaceutical concentrations in downstream site closely 
resembled those being measured (Fig 7.3b). Statistical analysis showed that the prediction 
underestimated measured values by 26%. But if one of the data points (i.e. carbamazepine 
on Monday) was excluded in the statistical analysis, then the underestimation from 
prediction was reduced to only 2.6%, with a r
2
 value of 0.932, and a P value <0.001, 
suggesting a significant relationship. 
A further comparison was made between the weekly mean pharmaceutical concentrations 
in the effluent and the receiving river water. It is clear that for all compounds, their 
concentrations were higher in the downstream than in the upstream, and the highest 
concentrations were always found in effluent. For example, the mean concentration of 
propranolol in the effluent was 62 ng L
−1
. In comparison, lower concentrations were 
detected in the receiving river in downstream (36 ng L
−1
) and in upstream (4 ng L
−1
). The 
same trends were observable for other compounds (sulfamethoxazole, carbamazepine, 
indomethacine and diclofenac) when their concentrations were compared, further 
confirming the STW as a key source of pharmaceuticals into river Ouse. 
7.3.4. Risk assessment of pharmaceutical compounds 
Safety threshold values for pharmaceutical compounds are limited and often related to 
single compound-single organism toxicity studies. Many pharmaceutical compounds have 
not yet been studied as extensively as others and reliable toxicity data are limited to acute 
effects only. Cleuvers [21] studied the toxicity of a number of compounds to Daphnia 
magna including diclofenac, carbamazepine and propranolol. The EC50 values were found 
to be 68, 72 and 7.5 mg L
−1
 respectively, which are substantially higher in comparison to 
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the concentrations measured in this study at ng L
−1
 range. Nevertheless, it must be noted 
that the impact of a mixture of these chemicals could prove more toxic than the individual 
compounds alone. For example, Flaherty and Dodson [22] found that pharmaceutical 
mixtures behaved unpredictably and caused serious side effects such as deformities and 
increased mortality in D. magna. 
Due to low pharmaceutical concentrations found in natural waters, their impact in causing 
chronic toxicity to aquatic populations close to sewage effluents is of more importance. 
Recently when studying cytological effects of pharmaceuticals in rainbow trout 
(Oncorhynchus mykiss) and common carp (Cyprinus carpio), Triebskorn et al. [23] 
determined that the lowest observed effect concentrations (LOEC) for carbamazepine and 
diclofenac were 1 μg L−1. Although the highest pharmaceutical concentration (334 ng L−1 
of carbamazepine) in the river Ouse is still lower than its LOEC, the safety margin becomes 
relatively constrained. Furthermore, due to the more significant impacts from mixtures of 
pollutants and potential persistence of such chemicals, it is prudent that these chemicals 
should be monitored regularly. 
7.4. Conclusions 
Five pharmaceutical compounds propranolol, sulfamethoxazole, carbamazepine, 
indomethacine and diclofenac were frequently detected in wastewater and river water 
samples, suggesting their widespread use and some degree of persistence. Pharmaceuticals 
were found to vary in concentrations, with carbamazepine being the most abundant. During 
wastewater treatment, all compounds were found to show concentration decline from 
influent to effluent, with removal efficiency from 43 to 92%. These compounds were also 
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found in both the upstream and downstream of the effluent outfall at Scaynes Hill STW, 
with concentrations elevated at the outfall. Through a simple dilution model, the STW was 
shown to be a key source of pharmaceuticals in the river Ouse. Further research is needed 
to assess potential bioaccumulation of pharmaceuticals in aquatic organisms and resulting 
chronic toxic effects. 
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Chapter 8. Conclusions and Further works and further work 
8.1 Monitoring of EDCs and PPCPs in UK rivers 
The GC-MS/MS and LC-MS/MS techniques described have been shown to be suitable for 
the determination of EDCs and Pharmaceutical pollutants in aquatic environments, with 
good agreement between the two techniques as well as with other analytical techniques and 
modelling approaches. The two techniques have been used to determine the concentrations 
of both classes of pollutants in two major UK rivers;  the Ouse (Sussex) and Ray 
(Wiltshire). In both rivers, concentration data indicates that STWs are the major source of 
these compounds into the river waters. Prior to the commissioning of a Granular Activated 
Carbon treatment plant at the Rodbourne STW, the effluent of which enters the River Ray, 
the contaminant profile of the River Ray was broadly comparable to those of similar rivers 
in the UK and internationally. There was a reduction in concentrations of EDCs and 
pharmaceuticals in the River Ray after the introduction of the GAC plant, suggesting a 
reduction in the risk posed by these chemicals. However, as some pharmaceutical 
compounds were found to persist GAC treatment, the risk that these pose remains a cause 
for concern.  
8.2 Analytical Procedures  
Analysis of emerging pollutants remains an area of development. To ensure valid risk 
assessment, reliable techniques for the quantification of these ultra-trace contaminants is a 
concern, particularly where potentially-toxic concentrations are sufficiently low so as to 
push instrumental techniques to their detection limits. Since mass-spectrometric 
instruments are relatively expensive to purchase, an assessment of three common 
techniques has been completed and has shown that whilst GC-MS/MS offers optimal 
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sensitivity, GC-MS and LC-MS/MS are suitable alternatives in some cases. All three 
techniques have been shown to have good agreement with alternative techniques, including 
yeast assays and modelling approaches, highlighting the potential of these techniques to be 
used where access to mass spectrometric instrumentation is not available.  
A significant source of uncertainty has been identified in the storage of environmental 
samples. Literature surveys revealed that often, information relating to the preservation and 
storage of samples is limited, and the implications that this may have for risk assessment 
and the comparison of results from different studies has been revealed. It has been 
suggested in this work that as a result, further work is required to identify more effective 
preservation techniques, as well as in focussing efforts to streamline sampling processing 
techniques to reduce the time samples need to be stored. 
8.3 Removal of emerging pollutants by STWs  
It has been shown that STWs do not entirely remove pharmaceuticals or estrogenic 
compounds present in sewage. As a result effluents released in to receiving river water is 
contaminated with potentially significant concentrations of these compounds. Results from 
a three-year study on the River Ray has shown that GAC treatment significantly reduces 
concentrations of three potent estrogenic compounds, but is less effective at removing some 
pharmaceutical substances. In light of this, it is suggested that further work to investigate 
the efficacy of GAC in the removal of pharmaceutical compounds is conducted, 
specifically to investigate how the conditions of GAC operation might improve removal. 
However, with GAC being an expensive treatment technique to implement, both in regard 
to initial set-up as well as maintenance, research into alternatives which are more effective 
and cost-efficient, such as UV-treatment could be pursued.   
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